Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Inflamm Bowel Dis

Retrieve available abstracts of 850 articles:
HTML format
Text format



Single Articles


    August 2018
  1. BERNARDO S, Fernandes SR, Goncalves AR, Valente A, et al
    Predicting the Course of Disease in Hospitalized Patients With Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067145. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. SITKIN S, Pokrotnieks J
    Clinical Potential of Anti-inflammatory Effects of Faecalibacterium prausnitzii and Butyrate in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067149. doi: 10.1093.
    PubMed     Text format    


  3. GUADAGNO E, De Rosa F, Borrelli G, Luglio G, et al
    High-grade MiNEN in a Long-standing History of Ulcerative Colitis: An Unexpected Evolution.
    Inflamm Bowel Dis. 2018 Aug 6. pii: 5067338. doi: 10.1093.
    PubMed     Text format    


  4. TEN HOVE JR, Bogaerts JMK, Bak MTJ, Lacle MM, et al
    Malignant and Nonmalignant Complications of the Rectal Stump in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Aug 1. pii: 5063333. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  5. OUAHED J, Gordon W, Canavan JB, Zhou H, et al
    Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis.
    Inflamm Bowel Dis. 2018 Jul 31. pii: 5062951. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. LAMBDIN JT, Borum M
    Cervical Cancer Screening in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 31. pii: 5061940. doi: 10.1093.
    PubMed     Text format    


  7. WATT PJ, Irving MA
    A Diagnosis of Inflammatory Bowel Disease and Access to Psychotherapy: Rural Patients Who Accept Treatment Report Psychosomatic Benefits.
    Inflamm Bowel Dis. 2018 Jul 21. pii: 5056917. doi: 10.1093.
    PubMed     Text format    


  8. TINSLEY A, Navabi S, Williams ED, Liu G, et al
    Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 18. pii: 5055346. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. PORTER RJ, Andrews C, Brice DP, Durum SK, et al
    Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2018 Jul 18. pii: 5055343. doi: 10.1093.
    PubMed     Text format     Abstract available



  10. Corrigendum to Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2018 Jul 17. pii: 5054631. doi: 10.1093.
    PubMed     Text format    


  11. VOLK N, Siegel CA
    Defining Failure of Medical Therapy for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 16. pii: 5054534. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. TORMEY LK, Reich J, Chen YS, Singh A, et al
    Limited Health Literacy Is Associated With Worse Patient-Reported Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 10. pii: 5051146. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. BERNSTEIN CN, Hitchon CA, Walld R, Bolton JM, et al
    Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 7. pii: 5050505. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. WREN AA, Bensen R, Sceats L, Dehghan M, et al
    Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015.
    Inflamm Bowel Dis. 2018 Jul 7. pii: 5050495. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. KUENZIG ME, Benchimol EI
    Chronic Opioid Use Among Youth With Inflammatory Bowel Disease: A New Approach Is Needed.
    Inflamm Bowel Dis. 2018 Jul 7. pii: 5050494. doi: 10.1093.
    PubMed     Text format    


  16. REINISCH W, Colombel JF, Gibson PR, Rutgeerts P, et al
    Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab.
    Inflamm Bowel Dis. 2018 Jul 6. pii: 5049378. doi: 10.1093.
    PubMed     Text format     Abstract available



  17. Corrigendum to Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jul 5. pii: 5049267. doi: 10.1093.
    PubMed     Text format    


  18. KHAN N, Trivedi C, Kavani H, Lewis J, et al
    Frequency of Herpes Zoster Vaccination Among Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2018 Jul 5. pii: 5049271. doi: 10.1093.
    PubMed     Text format     Abstract available



  19. Corrigendum to Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018 Jul 5. pii: 5049258. doi: 10.1093.
    PubMed     Text format    


  20. MAHADEVAN U, Dubinsky MC, Su C, Lawendy N, et al
    Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Jul 2. pii: 5047917. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  21. SMITS LJT, van Esch AAJ, Derikx LAAP, Boshuizen R, et al
    Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study.
    Inflamm Bowel Dis. 2018 Jun 27. pii: 5045878. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. SHIVASHANKAR R, Lichtenstein GR
    Mimics of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jun 27. pii: 5045858. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. XUE M, Shi L, Wang W, Chen S, et al
    An Overview of Molecular Profiles in Ulcerative Colitis-Related Cancer.
    Inflamm Bowel Dis. 2018 Jun 25. pii: 5044833. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. VIADA BRIS JF, Velasco Rodriguez-Belvis M, de Lucas Collantes C, Aparicio Lopez C, et al
    Ulcerative Colitis and Atypical Hemolytic-Uremic Syndrome: An Unusual But Potentially Life-threating Life Complication.
    Inflamm Bowel Dis. 2018 Jun 20. pii: 5040737. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. TAIDA T, Arai M, Fujie M, Akizue N, et al
    Real-time Endoscopy-Guided Measurement of Rectal Mucosal Admittance Is a Novel and Safe Method for Predicting Ulcerative Colitis Relapse.
    Inflamm Bowel Dis. 2018 Jun 19. pii: 5040214. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. PICORARO JA, Lee D, Heller CA, Weaver A, et al
    Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD.
    Inflamm Bowel Dis. 2018 Jun 19. pii: 5040260. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. BOSSUYT P, Baert F, D'Heygere F, Nakad A, et al
    Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort.
    Inflamm Bowel Dis. 2018 Jun 15. pii: 5038936. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. LEE CK, Melmed GY, Mann A, Danovitch I, et al
    A Multidisciplinary Approach to Biopsychosocial Care for Adults With Inflammatory Bowel Disease: A Pilot Study.
    Inflamm Bowel Dis. 2018 Jun 15. pii: 5038934. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. PHILPOTT JR, Kurowski JA
    Challenges in Transitional Care in Inflammatory Bowel Disease: A Review of the Current Literature in Transition Readiness and Outcomes.
    Inflamm Bowel Dis. 2018 Jun 11. pii: 5035657. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. SLONIM-NEVO V, Sarid O, Friger M, Schwartz D, et al
    Effect of Social Support on Psychological Distress and Disease Activity in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2018;24:1389-1400.
    PubMed     Text format     Abstract available


  31. TYLER CJ, Perez-Jeldres T, Ehinger E, Capaldo B, et al
    Implementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jun 8. pii: 5034710. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. WHITEOAK SR, Claridge A, Balendran CA, Harris RJ, et al
    MicroRNA-31 Targets Thymic Stromal Lymphopoietin in Mucosal Infiltrated CD4+ T Cells: A Role in Achieving Mucosal Healing in Ulcerative Colitis?
    Inflamm Bowel Dis. 2018 Jun 8. pii: 5034803. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. WHALEY KG, Rosen MJ
    Contemporary Medical Management of Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Jun 7. pii: 5034511. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. RYAN E, McNicholas D, Creavin B, Kelly ME, et al
    Sarcopenia and Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2018 Jun 7. pii: 5034590. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. BLAZQUEZ ML, Hernani MT, Calatayud GA, Gonzalez-Pinto LC, et al
    Transition Care Program of Adolescents With Inflammatory Bowel Disease: Perceptions From A Survey for Patients.
    Inflamm Bowel Dis. 2018 Jun 5. pii: 5033090. doi: 10.1093.
    PubMed     Text format    


  36. ATREJA A
    Smarter Care for Patients With Inflammatory Bowel Disease: A Necessity for IBD Home, Value-Based Health Care and Treat-to-Target Strategies.
    Inflamm Bowel Dis. 2018 Jun 4. pii: 5032596. doi: 10.1093.
    PubMed     Text format    


  37. KELSO M, Feagins LA
    Can Smartphones Help Deliver Smarter Care for Patients With Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2018 Jun 4. pii: 5032595. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  38. ANDERSON A, Click B, Ramos-Rivers C, Koutroubakis IE, et al
    The Association Between Sustained Poor Quality of Life and Future Opioid Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 31. pii: 5025926. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. WINTHROP KL, Melmed GY, Vermeire S, Long MD, et al
    Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
    Inflamm Bowel Dis. 2018 May 30. pii: 5025191. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. WIERSTRA K, Sutton R, Bal J, Ismond K, et al
    Innovative Online Educational Portal Improves Disease-Specific Reproductive Knowledge Among Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 30. pii: 5025410. doi: 10.1093.
    PubMed     Text format     Abstract available


  41. CHANDRADEVAN R, Hofmekler T, Mondal K, Harun N, et al
    Evolution of Pediatric Inflammatory Bowel Disease Unclassified (IBD-U): Incorporated With Serological and Gene Expression Profiles.
    Inflamm Bowel Dis. 2018 May 30. pii: 5025792. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. ELIA J, Kane S
    Adult Inflammatory Bowel Disease, Physical Rehabilitation, and Structured Exercise.
    Inflamm Bowel Dis. 2018 May 29. pii: 5020214. doi: 10.1093.
    PubMed     Text format     Abstract available


  43. CHUDY-ONWUGAJE K, Abutaleb A, Buchwald A, Langenberg P, et al
    Age Modifies the Association Between Depressive Symptoms and Adherence to Self-Testing With Telemedicine in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 28. pii: 5017268. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. KHANNA R, Narula N, Feagan BG
    The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 28. pii: 5017276. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. HOSOE N, Nakano M, Takeuchi K, Endo Y, et al
    Establishment of a Novel Scoring System for Colon Capsule Endoscopy to Assess the Severity of Ulcerative Colitis-Capsule Scoring of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 26. pii: 5011158. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. BESSISSOW T, Dulai PS, Restellini S, Landry T, et al
    Comparison of Endoscopic Dysplasia Detection Techniques in Patients With Ulcerative Colitis: A Systematic Review and Network Meta-analysis.
    Inflamm Bowel Dis. 2018 May 25. pii: 5004810. doi: 10.1093.
    PubMed     Text format     Abstract available


  47. SOFIA MA, Ciorba MA, Meckel K, Lim CK, et al
    Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 22. pii: 5001501. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. PENG K, Qian X, Huang Z, Lu J, et al
    Umbilical Cord Blood Transplantation Corrects Very Early-Onset Inflammatory Bowel Disease in Chinese Patients With IL10RA-Associated Immune Deficiency.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999329. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. BOSCH S, van Gaal N, Zuurbier RP, Covington JA, et al
    Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999303. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. SPAGNUOLO R, Dattilo V, D'Antona L, Cosco C, et al
    Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999450. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. DORREEN A, Heisler C, Jones J
    Treatment of Inflammatory Bowel Disease in the Older Patient.
    Inflamm Bowel Dis. 2018;24:1155-1166.
    PubMed     Text format     Abstract available


  52. SZETO W, van der Bent A, Petty CR, Reich J, et al
    Use of Social Media for Health-Related Tasks by Adolescents With Inflammatory Bowel Disease: A Step in the Pathway of Transition.
    Inflamm Bowel Dis. 2018;24:1114-1122.
    PubMed     Text format     Abstract available


  53. SUH JH, Degagne E, Gleghorn EE, Setty M, et al
    Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study.
    Inflamm Bowel Dis. 2018;24:1321-1334.
    PubMed     Text format     Abstract available


  54. DIBLEY L, Czuber-Dochan W, Woodward S, Wade T, et al
    Development and Psychometric Properties of the Inflammatory Bowel Disease Distress Scale (IBD-DS): A New Tool to Measure Disease-Specific Distress.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999398. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. KOPYLOV U, Verstockt B, Biedermann L, Sebastian S, et al
    Effectiveness and Safety of Vedolizumab in Anti-TNF-Naive Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999380. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. SHMIDT E, Kochhar G, Hartke J, Chilukuri P, et al
    Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999184. doi: 10.1093.
    PubMed     Text format     Abstract available


  57. MITCHELL NE, Harrison N, Junga Z, Singla M, et al
    Heart Under Attack: Cardiac Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999386. doi: 10.1093.
    PubMed     Text format     Abstract available


  58. KHANNA R, Zou G, Feagan BG
    Evolution of the Randomized Controlled Trial in Inflammatory Bowel Disease: Current Challenges and Future Solutions.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999190. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. ZHANG M, Merlin D
    Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999330. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. ABUTALEB A, Buchwald A, Chudy-Onwugaje K, Langenberg P, et al
    Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999387. doi: 10.1093.
    PubMed     Text format     Abstract available


  61. MERKER AM, Riaz M, Friedman S, Allegretti JR, et al
    Legalization of Medicinal Marijuana Has Minimal Impact on Use Patterns in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999337. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. BARNES EL, Kochar B, Long MD, Pekow J, et al
    Lack of Difference in Treatment Patterns and Clinical Outcomes Between Black and White Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 18. pii: 4999440. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. NAVABI S, Gorrepati VS, Yadav S, Chintanaboina J, et al
    Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999008. doi: 10.1093.
    PubMed     Text format     Abstract available


  64. HARTMAN DJ, Binion DG, Regueiro MD, Miller C, et al
    Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998978. doi: 10.1093.
    PubMed     Text format     Abstract available


  65. YUNG DE, Horesh N, Lightner AL, Ben-Horin S, et al
    Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998839. doi: 10.1093.
    PubMed     Text format     Abstract available


  66. LIU R, Tang A, Wang X, Shen S, et al
    Assessment of Quality of Life in Chinese Patients With Inflammatory Bowel Disease and their Caregivers.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999056. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. ZHENG C, Huang Y, Ye Z, Wang Y, et al
    Infantile Onset Intractable Inflammatory Bowel Disease Due to Novel Heterozygous Mutations in TNFAIP3 (A20).
    Inflamm Bowel Dis. 2018 May 17. pii: 4999659. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. HEMPERLY A, Sandborn WJ, Vande Casteele N
    Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998913. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. KOSLOWSKY B, Grisaru-Granovsky S, Livovsky DM, Milgrom Y, et al
    Pregnancy-Onset Inflammatory Bowel Disease: A Subtle Diagnosis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998813. doi: 10.1093.
    PubMed     Text format     Abstract available


  70. AL-AMODI O, Jodeleit H, Beigel F, Wolf E, et al
    CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998980. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. RESTELLINI S, Khanna R, Afif W
    Therapeutic Drug Monitoring With Ustekinumab and Vedolizumab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999007. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. GORREPATI VS, Stuart A, Deiling S, Koltun W, et al
    Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients With Ileal Pouch-Anal Anastomosis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999006. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. DAI C, Jiang M, Sun MJ
    Prediagnostic Serum Vitamin D Levels and the Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999019. doi: 10.1093.
    PubMed     Text format    


  74. MOTTA JP, Allain T, Green-Harrison LE, Groves RA, et al
    Iron Sequestration in Microbiota Biofilms As A Novel Strategy for Treating Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 17. pii: 4997020. doi: 10.1093.
    PubMed     Text format     Abstract available


  75. MADSEN KG, Pottegard A, Hallas J, Kjeldsen J, et al
    Treatment Failure of TNF-alpha Inhibitors in Obese Patients With Inflammatory Bowel Disease-A Cohort Study.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998912. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. COLOMBEL JF
    Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention.
    Inflamm Bowel Dis. 2018 May 17. pii: 4998802. doi: 10.1093.
    PubMed     Text format     Abstract available


  77. LIGHTNER AL
    A Cell-Based Approach to the Treatment of Inflammatory Bowel Disease-Entering an Era of Regenerative Medicine.
    Inflamm Bowel Dis. 2018 May 17. pii: 4999009. doi: 10.1093.
    PubMed     Text format     Abstract available


  78. JIAN L, Anqi H, Gang L, Litian W, et al
    Food Exclusion Based on IgG Antibodies Alleviates Symptoms in Ulcerative Colitis: A Prospective Study.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996921. doi: 10.1093.
    PubMed     Text format     Abstract available


  79. ROBERTS RL, Wallace MC, Seinen ML, van Bodegraven AA, et al
    Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996867. doi: 10.1093.
    PubMed     Text format     Abstract available


  80. LI L, Huang S, Wang H, Chao K, et al
    Cytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the miR21-CLDN8 Pathway.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996911. doi: 10.1093.
    PubMed     Text format     Abstract available


  81. WEIMERS P, Halfvarson J, Sachs MC, Saunders-Pullman R, et al
    Inflammatory Bowel Disease and Parkinson's Disease: A Nationwide Swedish Cohort Study.
    Inflamm Bowel Dis. 2018 May 16. pii: 4996912. doi: 10.1093.
    PubMed     Text format     Abstract available


  82. BEGGS AD, James J, Caldwell G, Prout T, et al
    Discovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia.
    Inflamm Bowel Dis. 2018 May 14. pii: 4995684. doi: 10.1093.
    PubMed     Text format     Abstract available


  83. BIANCARDI AL, Zaltman C, Troncoso LL, Luiz RR, et al
    The Role of Clinical-Demographic Characteristics in Ophthalmic Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 11. pii: 4995039. doi: 10.1093.
    PubMed     Text format    


  84. MOON CM, Kim SW, Ahn JB, Ma HW, et al
    Deep Resequencing of Ulcerative Colitis-Associated Genes Identifies Novel Variants in Candidate Genes in the Korean Population.
    Inflamm Bowel Dis. 2018 May 4. pii: 4992873. doi: 10.1093.
    PubMed     Text format     Abstract available


  85. ROBLIN X, Riviere P, Flamant M, Veyrard P, et al
    Proactive Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 May 3. pii: 4992140. doi: 10.1093.
    PubMed     Text format     Abstract available


  86. WENG MT, Park SH, Matsuoka K, Tung CC, et al
    Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study.
    Inflamm Bowel Dis. 2018 May 3. pii: 4991928. doi: 10.1093.
    PubMed     Text format     Abstract available


  87. BARBER GE, Hendler S, Okafor P, Limsui D, et al
    Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis.
    Inflamm Bowel Dis. 2018 May 2. pii: 4990922. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  88. OKABAYASHI S, Kobayashi T, Nakano M, Toyonaga T, et al
    A Simple 1-Day Colon Capsule Endoscopy Procedure Demonstrated to be a Highly Acceptable Monitoring Tool for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990576. doi: 10.1093.
    PubMed     Text format     Abstract available


  89. SPENCER EA, Davis SM, Mack DR, Boyle BM, et al
    Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990334. doi: 10.1093.
    PubMed     Text format     Abstract available


  90. THEODORAKI E, Orfanoudaki E, Foteinogiannopoulou K, Koutroubakis IE, et al
    Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990625. doi: 10.1093.
    PubMed     Text format     Abstract available


  91. LEWIS JD
    Inflammatory Bowel Disease Care: What to Do When There Is a Breach of Contract between the Patient and Physician?
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990352. doi: 10.1093.
    PubMed     Text format     Abstract available


  92. BURKE KE, Khalili H, Garber JJ, Haritunians T, et al
    Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990575. doi: 10.1093.
    PubMed     Text format     Abstract available


  93. PATIL SA, Cross RK
    Current Landscape of Telemedicine Practice in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 28. pii: 4989997. doi: 10.1093.
    PubMed     Text format     Abstract available


  94. WU B, Wang Z, Zhang Q
    Cost-Effectiveness of Different Strategies for the Treatment of Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 27. pii: 4989472. doi: 10.1093.
    PubMed     Text format     Abstract available


  95. CHI LY, Zitomersky NL, Liu E, Tollefson S, et al
    The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4987131. doi: 10.1093.
    PubMed     Text format     Abstract available


  96. KATSANOS KH, Kyriakidi K, Skamnelos A, Christodoulou DK, et al
    Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4990626. doi: 10.1093.
    PubMed     Text format    


  97. RAMOS GP, Stroh G, Al-Bawardy B, Faubion WA, et al
    Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4987150. doi: 10.1093.
    PubMed     Text format     Abstract available


  98. DIEDEREN K, Krom H, Koole JCD, Benninga MA, et al
    Diet and Anthropometrics of Children With Inflammatory Bowel Disease: A Comparison With the General Population.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985538. doi: 10.1093.
    PubMed     Text format     Abstract available


  99. GREENER T, Kabakchiev B, Hillary Steinhart A, Silverberg MS, et al
    Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985513. doi: 10.1093.
    PubMed     Text format     Abstract available


  100. KHAN N, Trivedi C, Shah Y, Cole E, et al
    The Natural History of Newly Diagnosed Ulcerative Colitis in Patients with Concomitant Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985719. doi: 10.1093.
    PubMed     Text format     Abstract available


  101. DANESE S, D'Amico F, Bonovas S, Peyrin-Biroulet L, et al
    Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985510. doi: 10.1093.
    PubMed     Text format     Abstract available


  102. LEGA S, Dubinsky MC
    What Are the Targets of Inflammatory Bowel Disease Management.
    Inflamm Bowel Dis. 2018 Apr 25. pii: 4985529. doi: 10.1093.
    PubMed     Text format     Abstract available


  103. BERINSTEIN JA, Waljee AK, Stidham RW, Higgins PDR, et al
    The IBD SGI Diagnostic Test Is Frequently Used by Non-gastroenterologists to Screen for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:e18.
    PubMed     Text format    


  104. CHIBA M, Sugawara T, Komatsu M, Tozawa H, et al
    Onset of Ulcerative Colitis in the Second Trimester after Emesis Gravidarum: Treatment with Plant-based Diet.
    Inflamm Bowel Dis. 2018;24:e8-e9.
    PubMed     Text format    


  105. ROLLI V, Macquin C, Kokten T, Hablot J, et al
    Zinc-Alpha-2-Glycoprotein in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:e10.
    PubMed     Text format    


  106. KOCHHAR G, Steele S, Sanaka M, Gorgun E, et al
    Endoscopic Submucosal Dissection for Flat Colonic Polyps in Patients With Inflammatory Bowel Disease, A Single-Center Experience.
    Inflamm Bowel Dis. 2018;24:e14-e15.
    PubMed     Text format    


  107. SHERMAN HOREV H, Rabinowitz KM, Elad H, Barkan R, et al
    Increase in Processing Factors Is Involved in Skewed MicroRNA Expression in Patients with Ulcerative Colitis Who Develop Small Intestine Inflammation after Pouch Surgery.
    Inflamm Bowel Dis. 2018;24:1045-1054.
    PubMed     Text format     Abstract available


  108. SULLIVAN SN
    Bullous Pyoderma Gangrenosum and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:e16-e17.
    PubMed     Text format    


  109. GAMWELL KL, Baudino MN, Bakula DM, Sharkey CM, et al
    Perceived Illness Stigma, Thwarted Belongingness, and Depressive Symptoms in Youth With Inflammatory Bowel Disease (IBD).
    Inflamm Bowel Dis. 2018;24:960-965.
    PubMed     Text format     Abstract available


  110. YE L, Jiang Z, Liu J, Zhou W, et al
    Is There a New Classification of Inflammatory Bowel Disease (IBD)-Adult-Onset Mixed IBD.
    Inflamm Bowel Dis. 2018;24:e19-e20.
    PubMed     Text format    


  111. KNOWLES SR, Keefer L, Wilding H, Hewitt C, et al
    Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II.
    Inflamm Bowel Dis. 2018;24:966-976.
    PubMed     Text format     Abstract available


  112. BETTNER W, Rizzo A, Brant S, Dudley-Brown S, et al
    Low Incidence of Dysplasia and Colorectal Cancer Observed among Inflammatory Bowel Disease Patients with Prolonged Colonic Diversion.
    Inflamm Bowel Dis. 2018;24:1092-1098.
    PubMed     Text format     Abstract available


  113. MARIABEATRICE P, Andrea I, Giuseppe L, Michela M, et al
    Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors.
    Inflamm Bowel Dis. 2018 Apr 23. pii: 4982709. doi: 10.1093.
    PubMed     Text format     Abstract available


  114. SEVERS M, Spekhorst LM, Mangen MJ, Dijkstra G, et al
    Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies.
    Inflamm Bowel Dis. 2018 Apr 21. pii: 4980986. doi: 10.1093.
    PubMed     Text format     Abstract available


  115. AKHUEMONKHAN E, Parian A, Carson KA, Hutfless S, et al
    Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969822. doi: 10.1093.
    PubMed     Text format     Abstract available


  116. MEIJER B, Mulder CJJ, Bouma G, Ponsioen CY, et al
    Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969999. doi: 10.1093.
    PubMed     Text format     Abstract available


  117. AUTH MK, Bunn SK, Protheroe AL, Williams LJ, et al
    Improved Medical Treatment and Surgical Surveillance of Children and Adolescents with Ulcerative Colitis in the United Kingdom.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969914. doi: 10.1093.
    PubMed     Text format     Abstract available


  118. GULATI S, Emmanuel A, Burt M, Dubois P, et al
    Outcomes of Endoscopic Resections of Large Laterally Spreading Colorectal Lesions in Inflammatory Bowel Disease: a Single United Kingdom Center Experience.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969983. doi: 10.1093.
    PubMed     Text format     Abstract available


  119. SHUTKEVER O, Gracie DJ, Young C, Wood HM, et al
    No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4970060. doi: 10.1093.
    PubMed     Text format     Abstract available


  120. CARD T, Xu J, Liang H, Bhayat F, et al
    What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn's Disease Treated With Vedolizumab?
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969878. doi: 10.1093.
    PubMed     Text format     Abstract available


  121. HOSOMI S, Watanabe K, Nishida Y, Yamagami H, et al
    Combined Infection of Human Herpes Viruses: A Risk Factor for Subsequent Colectomy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969863. doi: 10.1093.
    PubMed     Text format     Abstract available


  122. VAN DE VONDEL S, Baert F, Reenaers C, Vanden Branden S, et al
    Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969974. doi: 10.1093.
    PubMed     Text format     Abstract available


  123. FLYNN AD, Valentine JF
    Chromoendoscopy for Dysplasia Surveillance in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969996. doi: 10.1093.
    PubMed     Text format     Abstract available


  124. WENTWORTH BJ, Buerlein RCD, Tuskey AG, Overby MA, et al
    Nonadherence to Biologic Therapies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969742. doi: 10.1093.
    PubMed     Text format     Abstract available


  125. DUBINSKY MC, Cross RK, Sandborn WJ, Long M, et al
    Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969986. doi: 10.1093.
    PubMed     Text format     Abstract available


  126. BERNSTEIN CN, Zhang L, Lix LM, Graff LA, et al
    The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969741. doi: 10.1093.
    PubMed     Text format     Abstract available


  127. MARK-CHRISTENSEN A, Laurberg S, Haboubi N
    Dysplasia in Inflammatory Bowel Disease: Historical Review, Critical Histopathological Analysis, and Clinical Implications.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4969836. doi: 10.1093.
    PubMed     Text format     Abstract available


  128. BUER LCT, Hoivik ML, Warren DJ, Medhus AW, et al
    Combining Anti-TNF-alpha and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series.
    Inflamm Bowel Dis. 2018 Apr 12. pii: 4969708. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  129. GU P, Kuenzig ME, Kaplan GG, Pimentel M, et al
    Fecal Incontinence in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2018 Mar 30. pii: 4916092. doi: 10.1093.
    PubMed     Text format     Abstract available


  130. DE SOUZA HSP, Fiocchi C
    Network Medicine: A Mandatory Next Step for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:671-679.
    PubMed     Text format     Abstract available


  131. KNOWLES SR, Graff LA, Wilding H, Hewitt C, et al
    Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I.
    Inflamm Bowel Dis. 2018;24:742-751.
    PubMed     Text format     Abstract available


  132. VENKATESWARAN S, Prince J, Cutler DJ, Marigorta UM, et al
    Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:829-838.
    PubMed     Text format     Abstract available


  133. LEE WJ, Lee TA, Calip GS, Suda KJ, et al
    Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:883-891.
    PubMed     Text format     Abstract available


  134. CHRISTENSEN B, Colman RJ, Micic D, Gibson PR, et al
    Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
    Inflamm Bowel Dis. 2018;24:849-860.
    PubMed     Text format     Abstract available


  135. VORTIA E, Uko VE, Yen-Lieberman B, Frawley J, et al
    Low Indeterminate Rates Associated With Use of the QuantiFERON-TB Gold In-Tube Test in Children With Inflammatory Bowel Disease on Long-term Infliximab.
    Inflamm Bowel Dis. 2018;24:877-882.
    PubMed     Text format     Abstract available


  136. IRVING PM, Iqbal T, Nwokolo C, Subramanian S, et al
    A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Mar 10. pii: 4925788. doi: 10.1093.
    PubMed     Text format     Abstract available


  137. SHIRAI S, Hara M, Sakata Y, Tsuruoka N, et al
    Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy.
    Inflamm Bowel Dis. 2018 Mar 9. pii: 4925593. doi: 10.1093.
    PubMed     Text format     Abstract available


  138. MOUCHLI MA, Singh S, Boardman L, Bruining DH, et al
    Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924363. doi: 10.1093.
    PubMed     Text format     Abstract available


  139. AARDOOM MA, Linda Joosse ME, de Vries ACH, Levine A, et al
    Malignancy and Mortality in Pediatric-onset Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924482. doi: 10.1093.
    PubMed     Text format     Abstract available


  140. MARQUES DA COSTA P, Correia L, Correia LA
    The Complexity of Renal Involvment in IBD-C3 Glomerulopathy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924366. doi: 10.1093.
    PubMed     Text format    


  141. LITSTER B, Bernstein CN, Graff LA, Walker JR, et al
    Validation of the PHQ-9 for Suicidal Ideation in Persons with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924383. doi: 10.1093.
    PubMed     Text format     Abstract available


  142. KHAN N, Trivedi C, Shah Y, Patel D, et al
    The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents.
    Inflamm Bowel Dis. 2018 Mar 7. pii: 4924495. doi: 10.1093.
    PubMed     Text format     Abstract available


  143. LIGHTNER AL, Mathis KL, Tse CS, Pemberton JH, et al
    Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.
    Inflamm Bowel Dis. 2018 Mar 2. pii: 4917693. doi: 10.1093.
    PubMed     Text format     Abstract available


  144. DANION P, Buisson A, Roblin X, Mathieu N, et al
    IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Mar 1. pii: 4916100. doi: 10.1093.
    PubMed     Text format     Abstract available


  145. PATEL P, Yarur A, Dalal S, Sakuraba A, et al
    Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
    Inflamm Bowel Dis. 2018 Mar 1. pii: 4916098. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  146. KAMMERLANDER H, Nielsen J, Kjeldsen J, Knudsen T, et al
    Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Feb 28. pii: 4913664. doi: 10.1093.
    PubMed     Text format     Abstract available


  147. DA SILVA S, Keita AV, Mohlin S, Pahlman S, et al
    A Novel Topical PPARgamma Agonist Induces PPARgamma Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
    Inflamm Bowel Dis. 2018 Feb 24. pii: 4909417. doi: 10.1093.
    PubMed     Text format     Abstract available


  148. REZAIE A, Gu P, Kaplan GG, Pimentel M, et al
    Dyssynergic Defecation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2018 Feb 24. pii: 4909412. doi: 10.1093.
    PubMed     Text format     Abstract available


  149. ZAMORA C, Canto E, Nieto JC, Garcia-Planella E, et al
    Inverse Association Between Circulating Monocyte-Platelet Complexes and Inflammation in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Feb 23. pii: 4908015. doi: 10.1093.
    PubMed     Text format     Abstract available


  150. KATSANOS KH, Papamichael K, Cheifetz AS, Christodoulou DK, et al
    Full Interchangeability in Regards to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:465-466.
    PubMed     Text format    


  151. UHLIG HH
    Mendelian Diseases and Inflammatory Bowel Disease-Data Mining for Genetic Risk and Disease-Associated Confounders.
    Inflamm Bowel Dis. 2018;24:467-470.
    PubMed     Text format    


  152. HAN L, Maciejewski M, Brockel C, Afzelius L, et al
    Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:471-481.
    PubMed     Text format     Abstract available


  153. FIORINO G, Ruiz-Arguello MB, Maguregui A, Nagore D, et al
    Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:601-606.
    PubMed     Text format     Abstract available


  154. EWELUKWA O, Perez R, Carter LE, Fernandez A, et al
    Incorporation of Scribes Into the Inflammatory Bowel Disease Clinic Improves Quality of Care and Physician Productivity.
    Inflamm Bowel Dis. 2018;24:552-557.
    PubMed     Text format     Abstract available


  155. DE ANGELIS PM, Schjolberg AR, Hughes JB, Huitfeldt HS, et al
    Nondysplastic Ulcerative Colitis Has High Levels of the Homologous Recombination Repair Protein NUCKS1 and Low Levels of the DNA Damage Marker Gamma-H2AX.
    Inflamm Bowel Dis. 2018;24:593-600.
    PubMed     Text format     Abstract available


  156. BHANDARI S, Saeian K, Stein D
    Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
    Inflamm Bowel Dis. 2018;24:661.
    PubMed     Text format    


  157. DAI C, Cao Q, Sun MJ
    Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium difficile Infection.
    Inflamm Bowel Dis. 2018;24:662.
    PubMed     Text format    


  158. ZHOU F, Hamza T, Fleur AS, Zhang Y, et al
    Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.
    Inflamm Bowel Dis. 2018;24:573-582.
    PubMed     Text format     Abstract available


  159. SAUER CG, Loop MS, Venkateswaran S, Tangpricha V, et al
    Free and Bioavailable 25-Hydroxyvitamin D Concentrations are Associated With Disease Activity in Pediatric Patients With Newly Diagnosed Treatment Naive Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:641-650.
    PubMed     Text format     Abstract available


  160. OPSTELTEN JL, Chan SSM, Hart AR, van Schaik FDM, et al
    Prediagnostic Serum Vitamin D Levels and the Risk of Crohn's Disease and Ulcerative Colitis in European Populations: A Nested Case-Control Study.
    Inflamm Bowel Dis. 2018;24:633-640.
    PubMed     Text format     Abstract available


  161. NORDENVALL C, Olen O, Johan Nilsson P, Ekbom A, et al
    Restorative Surgery in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis Following a Colectomy.
    Inflamm Bowel Dis. 2018;24:624-632.
    PubMed     Text format     Abstract available


  162. SHAH SC, Naymagon S, Panchal HJ, Sands BE, et al
    Accelerated Infliximab Dosing Increases 30-Day Colectomy in Hospitalized Ulcerative Colitis Patients: A Propensity Score Analysis.
    Inflamm Bowel Dis. 2018;24:651-659.
    PubMed     Text format     Abstract available


  163. GONCALVES P, Araujo JR, Di Santo JP
    A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:558-572.
    PubMed     Text format     Abstract available


    January 2018
  164. KANG B, Lee Y, Lee K, Choi YO, et al
    Long-term Outcomes After Switching to CT-P13 in Pediatric-Onset Inflammatory Bowel Disease: A Single-Center Prospective Observational Study.
    Inflamm Bowel Dis. 2018 Jan 30. pii: 4829375. doi: 10.1093.
    PubMed     Text format     Abstract available


  165. MOSHER CA, Brown GR, Weideman RA, Crook TW, et al
    Incidence of Colorectal Cancer and Extracolonic Cancers in Veteran Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Jan 30. pii: 4829349. doi: 10.1093.
    PubMed     Text format     Abstract available


  166. RAO BB, Lashner B, Kowdley KV
    Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Trasnplantation for Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2018;24:269-276.
    PubMed     Text format     Abstract available


  167. O'TOOLE A, de Silva PS, Marc LG, Ulysse CA, et al
    Sexual Dysfunction in Men With Inflammatory Bowel Disease: A New IBD-Specific Scale.
    Inflamm Bowel Dis. 2018;24:310-316.
    PubMed     Text format     Abstract available


  168. HUGUET M, Pereira B, Goutte M, Goutorbe F, et al
    Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018;24:261-268.
    PubMed     Text format     Abstract available


  169. SCOTT FI, Shah Y, Lasch K, Luo M, et al
    Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis: A Simulation Model.
    Inflamm Bowel Dis. 2018;24:286-295.
    PubMed     Text format     Abstract available


  170. YARLAS A, D'Haens G, Willian MK, Teynor M, et al
    Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study.
    Inflamm Bowel Dis. 2018;24:450-463.
    PubMed     Text format     Abstract available


  171. LARSEN L, Drewes AM, Broberg MCH, Fallingborg J, et al
    Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014.
    Inflamm Bowel Dis. 2018;24:433-439.
    PubMed     Text format     Abstract available


  172. PIESTER T, Frymoyer A, Christofferson M, Yu H, et al
    A Mobile Infliximab Dosing Calculator for Therapy Optimization in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:227-234.
    PubMed     Text format     Abstract available


  173. GOYAL A, Yeh A, Bush BR, Firek BA, et al
    Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:410-421.
    PubMed     Text format     Abstract available


  174. HABERMAN Y, BenShoshan M, Di Segni A, Dexheimer PJ, et al
    Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.
    Inflamm Bowel Dis. 2018;24:346-360.
    PubMed     Text format     Abstract available


  175. MACALUSO FS, Sapienza C, Ventimiglia M, Renna S, et al
    The Addition of an Immunosuppressant After Loss of Response to Anti-TNFalpha Monotherapy in Inflammatory Bowel Disease: A 2-Year Study.
    Inflamm Bowel Dis. 2018;24:394-401.
    PubMed     Text format     Abstract available


  176. ROLSTON VS, Boroujerdi L, Long MD, McGovern DPB, et al
    The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study.
    Inflamm Bowel Dis. 2018;24:387-393.
    PubMed     Text format     Abstract available


  177. PRATT PK JR, David N, Weber HC, Little FF, et al
    Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy.
    Inflamm Bowel Dis. 2018;24:380-386.
    PubMed     Text format     Abstract available


    December 2017
  178. BAKER DM, Lee MJ, Jones GL, Brown SR, et al
    The Informational Needs and Preferences of Patients Considering Surgery for Ulcerative Colitis: Results of a Qualitative Study.
    Inflamm Bowel Dis. 2017;24:179-190.
    PubMed     Text format     Abstract available


  179. VAN GENNEP S, de Boer NK, D'Haens GR, Lowenberg M, et al
    Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice.
    Inflamm Bowel Dis. 2017;24:67-77.
    PubMed     Text format     Abstract available


  180. GROSSBERG LB, Papamichael K, Feuerstein JD, Siegel CA, et al
    A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;24:191-197.
    PubMed     Text format     Abstract available


  181. KELSO M, Weideman RA, Cipher DJ, Feagins LA, et al
    Factors Associated With Length of Stay in Veterans With Inflammatory Bowel Disease Hospitalized for an Acute Flare.
    Inflamm Bowel Dis. 2017;24:5-11.
    PubMed     Text format     Abstract available


  182. VAJRAVELU RK, Osterman MT, Aberra FN, Roy JA, et al
    Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization.
    Inflamm Bowel Dis. 2017;24:217-226.
    PubMed     Text format     Abstract available


  183. AFZALI A, Ciorba MA, Schwartz DA, Sharaf M, et al
    Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned.
    Inflamm Bowel Dis. 2017;24:2-4.
    PubMed     Text format     Abstract available


  184. HUNDORFEAN G, Chiriac MT, Mihai S, Hartmann A, et al
    Development and Validation of a Confocal Laser Endomicroscopy-Based Score for In Vivo Assessment of Mucosal Healing in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2017;24:35-44.
    PubMed     Text format     Abstract available


  185. DI RUSCIO M, Vernia F, Ciccone A, Frieri G, et al
    Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?
    Inflamm Bowel Dis. 2017;24:78-92.
    PubMed     Text format     Abstract available


  186. NETZ U, Carter J, Eichenberger MR, Feagins K, et al
    Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;24:159-165.
    PubMed     Text format     Abstract available


  187. MYKLEBUST-HANSEN T, Aamodt G, Haugen M, Brantsaeter AL, et al
    Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa).
    Inflamm Bowel Dis. 2017;24:12-24.
    PubMed     Text format     Abstract available


  188. MARCHIONI BEERY RM, Barnes EL, Nadkarni A, Korzenik JR, et al
    Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis.
    Inflamm Bowel Dis. 2017;24:25-34.
    PubMed     Text format     Abstract available


  189. WALJEE AK, Lipson R, Wiitala WL, Zhang Y, et al
    Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning.
    Inflamm Bowel Dis. 2017;24:45-53.
    PubMed     Text format     Abstract available


  190. HYAMS JS, Chan D, Adedokun OJ, Padgett L, et al
    Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit.
    Inflamm Bowel Dis. 2017;23:2227-2237.
    PubMed     Text format     Abstract available


  191. BARNES EL, Kochar B, Long MD, Martin CF, et al
    Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay.
    Inflamm Bowel Dis. 2017;23:2189-2196.
    PubMed     Text format     Abstract available


  192. YE Z, Zhou Y, Huang Y, Wang Y, et al
    Phenotype and Management of Infantile-onset Inflammatory Bowel Disease: Experience from a Tertiary Care Center in China.
    Inflamm Bowel Dis. 2017;23:2154-2164.
    PubMed     Text format     Abstract available


  193. EL-MATARY W, Dykes DMH, Bauman L, Elkadri A, et al
    Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience.
    Inflamm Bowel Dis. 2017;23:2104-2108.
    PubMed     Text format     Abstract available


  194. SELINGER CP, Lenti MV, Clark T, Rafferty H, et al
    Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:2083-2088.
    PubMed     Text format     Abstract available


  195. ARSENEAU KKO, Cominelli F
    Improving the Reproducibility and Quality of Reporting for Animal Studies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:2069-2071.
    PubMed     Text format    


    November 2017
  196. SHIBATA W, Sohara M, Wu R, Kobayashi K, et al
    Incidence and Outcomes of Central Venous Catheter-related Blood Stream Infection in Patients with Inflammatory Bowel Disease in Routine Clinical Practice Setting.
    Inflamm Bowel Dis. 2017;23:2042-2047.
    PubMed     Text format     Abstract available


  197. HOPKINS CWP
    Inflammatory Bowel Disease, the Hospital Anxiety and Depression Scale and Criterion Contamination.
    Inflamm Bowel Dis. 2017;23:E54.
    PubMed     Text format    


    October 2017
  198. ANDERSON A, Click B, Ramos-Rivers C, Cheng D, et al
    Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001251.
    PubMed     Text format     Abstract available


  199. GAWRONSKA A, Banasiuk M, Lachowicz D, Pituch H, et al
    Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001249.
    PubMed     Text format     Abstract available


  200. ZHANG W, Teng G, Wu T, Tian Y, et al
    Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001252.
    PubMed     Text format     Abstract available


  201. SIGURDSSON GV, Schmidt S, Mellstrom D, Ohlsson C, et al
    Bone Mass Development from Childhood into Young Adulthood in Patients with Childhood-onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 20. doi: 10.1097/MIB.0000000000001277.
    PubMed     Text format     Abstract available


  202. CONRAD MA, Dawany N, Sullivan KE, Devoto M, et al
    Novel ZBTB24 Mutation Associated with Immunodeficiency, Centromere Instability, and Facial Anomalies Type-2 Syndrome Identified in a Patient with Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 11. doi: 10.1097/MIB.0000000000001280.
    PubMed     Text format     Abstract available


  203. PONTE A, Pinho R, Fernandes S, Rodrigues A, et al
    Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001275.
    PubMed     Text format     Abstract available


  204. ANANTHAKRISHNAN AN, Khalili H, Song M, Higuchi LM, et al
    Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001236.
    PubMed     Text format     Abstract available


  205. SO J, Tang W, Leung WK, Li M, et al
    Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001240.
    PubMed     Text format     Abstract available


  206. RIVIERE P, Poullenot F, Zerbib F, Laharie D, et al
    Quality of Sex Life in Patients with Inflammatory Bowel Disease: The Gastroenterologists' Perspective.
    Inflamm Bowel Dis. 2017;23:E51-E52.
    PubMed     Text format    


  207. CALDERA F, Wasan SK, Farraye FA, Hayney MS, et al
    Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E50-E51.
    PubMed     Text format    


  208. GALLINGER ZR, Rumman A, Pivovarov K, Fortinsky KJ, et al
    Frequency and Variables Associated with Fasting Orders in Inpatients with Ulcerative Colitis: The Audit of Diet Orders-Ulcerative Colitis (ADORE-UC) Study.
    Inflamm Bowel Dis. 2017;23:1790-1795.
    PubMed     Text format     Abstract available


  209. NARULA N, Kassam Z, Yuan Y, Colombel JF, et al
    Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1702-1709.
    PubMed     Text format     Abstract available


  210. CROSS RK
    Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1689-1701.
    PubMed     Text format     Abstract available


  211. LIU X, Yu R, Zhu L, Hou X, et al
    Bidirectional Regulation of Circadian Disturbance and Inflammation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:1741-1751.
    PubMed     Text format     Abstract available


    September 2017
  212. KRAWIEC P, Mroczkowska-Juchkiewicz A, Pac-Kozuchowska E
    Serum Hepcidin in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Sep 22. doi: 10.1097/MIB.0000000000001245.
    PubMed     Text format     Abstract available


  213. ROBLIN X, Boschetti G, Duru G, Williet N, et al
    Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study.
    Inflamm Bowel Dis. 2017 Sep 22. doi: 10.1097/MIB.0000000000001223.
    PubMed     Text format     Abstract available


  214. PETERSEN BS, August D, Abt R, Alddafari M, et al
    Targeted Gene Panel Sequencing for Early-onset Inflammatory Bowel Disease and Chronic Diarrhea.
    Inflamm Bowel Dis. 2017 Sep 19. doi: 10.1097/MIB.0000000000001235.
    PubMed     Text format     Abstract available


  215. NGUYEN VQ, Jiang D, Hoffman SN, Guntaka S, et al
    Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2017 Sep 6. doi: 10.1097/MIB.0000000000001257.
    PubMed     Text format     Abstract available


  216. VANCAMELBEKE M, Vanuytsel T, Farre R, Verstockt S, et al
    Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Sep 6. doi: 10.1097/MIB.0000000000001246.
    PubMed     Text format     Abstract available


  217. PARK KT, Heida A, van Rheenen PF
    Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E47.
    PubMed     Text format    


  218. DAI C, Cao Q, Jiang M
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E46-E47.
    PubMed     Text format    


  219. PAPAMICHAEL K, Casteele NV, Ferrante M, Gils A, et al
    Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.
    Inflamm Bowel Dis. 2017;23:1510-1515.
    PubMed     Text format     Abstract available


  220. TANG MS, Bowcutt R, Leung JM, Wolff MJ, et al
    Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells.
    Inflamm Bowel Dis. 2017;23:1544-1554.
    PubMed     Text format     Abstract available


    August 2017
  221. ALLEGRETTI J, Eysenbach LM, El-Nachef N, Fischer M, et al
    The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001247.
    PubMed     Text format     Abstract available


  222. LIGHTNER AL, McKenna NP, Moncrief S, Pemberton JH, et al
    Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001248.
    PubMed     Text format     Abstract available


  223. KONIJETI GG, Kim N, Lewis JD, Groven S, et al
    Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001221.
    PubMed     Text format     Abstract available


  224. KAMMERLANDER H, Nielsen J, Knudsen T, Kjeldsen J, et al
    Anti-TNF-alpha Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001234.
    PubMed     Text format     Abstract available


  225. MUDIREDDY P, Scott F, Feathers A, Lichtenstein GR, et al
    Inflammatory Bowel Disease: Predictors and Causes of Early and Late Hospital Readmissions.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001242.
    PubMed     Text format     Abstract available


  226. CALDERA F, Wasan SK, Farraye FA, Hayney MS, et al
    Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 23. doi: 10.1097/MIB.0000000000001239.
    PubMed     Text format    


  227. NARULA N, Kassam Z, Yuan Y, Colombel JF, et al
    Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Aug 23. doi: 10.1097/MIB.0000000000001228.
    PubMed     Text format     Abstract available


  228. HYAMS JS, Kugathasan S, Dubinsky MC
    Combination Therapy in Pediatric Inflammatory Bowel Disease: Yes, No, Maybe.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001206.
    PubMed     Text format    


  229. CHRISTIAN KE, Jambaulikar GD, Hagan MN, Syed AM, et al
    Predictors of Early Readmission in Hospitalized Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001213.
    PubMed     Text format     Abstract available


  230. GOLD SL, Cohen-Mekelburg S, Schneider Y, Shen N, et al
    Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001189.
    PubMed     Text format     Abstract available


  231. BHANDARI S, Mohammed Abdul MK, Dhakal B, Kreuziger LB, et al
    Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001218.
    PubMed     Text format     Abstract available


  232. CHENG J, Hamilton Z, Smyth M, Barker C, et al
    Concomitant Therapy with Immunomodulator Enhances Infliximab Durability in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001212.
    PubMed     Text format     Abstract available


  233. LU Y, Zamora-Ros R, Chan S, Cross AJ, et al
    Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC).
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001108.
    PubMed     Text format     Abstract available


  234. LI SX, Thompson KD, Peterson T, Huneven S, et al
    Delivering High Value Inflammatory Bowel Disease Care Through Telemedicine Visits.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001210.
    PubMed     Text format     Abstract available


  235. BRAMUZZO M, Stocco G, Montico M, Arrigo S, et al
    Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001195.
    PubMed     Text format     Abstract available


  236. KLAG T, Mazurak N, Fantasia L, Schwille-Kiuntke J, et al
    High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001216.
    PubMed     Text format     Abstract available


  237. PARK KT, Heida A, van Rheenen PF
    Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001229.
    PubMed     Text format    


  238. DAI C, Cao Q, Jiang M
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001225.
    PubMed     Text format    


  239. PAPAMICHAEL K, Casteele NV, Ferrante M, Gils A, et al
    Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001231.
    PubMed     Text format     Abstract available


  240. ISAKOV O, Dotan I, Ben-Shachar S
    Machine Learning-Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 8. doi: 10.1097/MIB.0000000000001222.
    PubMed     Text format     Abstract available


  241. MARIN-JIMENEZ I, Gobbo Montoya M, Panadero A, Canas M, et al
    Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients-The ENMENTE Project.
    Inflamm Bowel Dis. 2017 Aug 3. doi: 10.1097/MIB.0000000000001205.
    PubMed     Text format     Abstract available


  242. PEPE J, Zawadynski S, Herrmann FR, Juillerat P, et al
    Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC).
    Inflamm Bowel Dis. 2017;23:1410-1417.
    PubMed     Text format     Abstract available


  243. JOLVING LR, Nielsen J, Beck-Nielsen SS, Nielsen RG, et al
    The Association Between Maternal Chronic Inflammatory Bowel Disease and Long-term Health Outcomes in Children-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2017;23:1440-1446.
    PubMed     Text format     Abstract available


  244. SUN C, Zhao Y, Gao X, Yuan Y, et al
    Cideb Deficiency Aggravates Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice by Exacerbating the Oxidative Burden in Colonic Mucosa.
    Inflamm Bowel Dis. 2017;23:1338-1347.
    PubMed     Text format     Abstract available


  245. AL-DARMAKI A, Hubbard J, Seow CH, Leung Y, et al
    Clinical Predictors of the Risk of Early Colectomy in Ulcerative Colitis: A Population-based Study.
    Inflamm Bowel Dis. 2017;23:1272-1277.
    PubMed     Text format     Abstract available


  246. TIAO DK, Chan W, Jeganathan J, Chan JT, et al
    Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1257-1261.
    PubMed     Text format     Abstract available


    July 2017
  247. BAKER DM, Marshall JH, Lee MJ, Jones GL, et al
    A Systematic Review of Internet Decision-Making Resources for Patients Considering Surgery for Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001198.
    PubMed     Text format     Abstract available


  248. COHN HM, Dave M, Loftus EV Jr
    Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001199.
    PubMed     Text format     Abstract available


  249. AGUAS PERIS M, Boso V, Navarro B, Marques-Minana MR, et al
    Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001182.
    PubMed     Text format     Abstract available


  250. MARTIN T, Smukalla SM, Kane S, Hudesman DP, et al
    Receptive Anal Intercourse in Patients with Inflammatory Bowel Disease: A Clinical Review.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001186.
    PubMed     Text format     Abstract available


  251. VOSKENS CJ, Fischer A, Roessner S, Lorenz C, et al
    Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001192.
    PubMed     Text format     Abstract available


  252. SYED S, Michalski ES, Tangpricha V, Chesdachai S, et al
    Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001178.
    PubMed     Text format     Abstract available


  253. SEVERS M, Mangen MJ, Fidder HH, van der Valk ME, et al
    Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001201.
    PubMed     Text format     Abstract available


  254. MATSUNO H, Kayama H, Nishimura J, Sekido Y, et al
    CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001204.
    PubMed     Text format     Abstract available


  255. STARK CM, Gorman GH, Nylund CM
    Association of Inflammatory Bowel Disease and Urolithiasis in Hospitalized Pediatric Patients.
    Inflamm Bowel Dis. 2017 Jul 10. doi: 10.1097/MIB.0000000000001188.
    PubMed     Text format     Abstract available


  256. ROBER N, Noss L, Goihl A, Reinhold D, et al
    Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 6. doi: 10.1097/MIB.0000000000001159.
    PubMed     Text format     Abstract available


  257. JANMOHAMED N, Steinhart AH
    Measuring Severity of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Low Concordance Between Patients and Male Gastroenterologists.
    Inflamm Bowel Dis. 2017;23:1168-1173.
    PubMed     Text format     Abstract available


  258. KHALILI H, de Silva PS, Ananthakrishnan AN, Lochhead P, et al
    Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1088-1095.
    PubMed     Text format     Abstract available


    June 2017
  259. TAXONERA C, Rodriguez C, Bertoletti F, Menchen L, et al
    Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jun 30. doi: 10.1097/MIB.0000000000001144.
    PubMed     Text format     Abstract available


  260. MA C, Lumb R, Walker EV, Foshaug RR, et al
    Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2017 Jun 20. doi: 10.1097/MIB.0000000000001173.
    PubMed     Text format     Abstract available


  261. CARLSEN K, Houen G, Jakobsen C, Kallemose T, et al
    Individualized Infliximab Treatment Guided by Patient-managed eHealth in Children and Adolescents with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001170.
    PubMed     Text format     Abstract available


  262. MEIJER B, Seinen ML, van Egmond R, Bouma G, et al
    Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001168.
    PubMed     Text format     Abstract available


  263. EPPINGA H, Poortinga S, Thio HB, Nijsten TEC, et al
    Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001169.
    PubMed     Text format     Abstract available


  264. PEDERSEN M, Cromwell J, Nau P
    Sarcopenia is a Predictor of Surgical Morbidity in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 9. doi: 10.1097/MIB.0000000000001166.
    PubMed     Text format     Abstract available


  265. PEKOW J, Hutchison AL, Meckel K, Harrington K, et al
    miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
    Inflamm Bowel Dis. 2017 Jun 7. doi: 10.1097/MIB.0000000000001104.
    PubMed     Text format     Abstract available


  266. KOPYLOV U, Papamichael K, Katsanos K, Waterman M, et al
    Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017 Jun 5. doi: 10.1097/MIB.0000000000001160.
    PubMed     Text format     Abstract available


  267. PATEL A, Panchal H, Dubinsky MC
    Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jun 5. doi: 10.1097/MIB.0000000000001157.
    PubMed     Text format     Abstract available


  268. AXELRAD JE, Joelson A, Nobel YR, Lawlor G, et al
    Enteric Infection in Relapse of Inflammatory Bowel Disease: The Utility of Stool Microbial PCR Testing.
    Inflamm Bowel Dis. 2017;23:1034-1039.
    PubMed     Text format     Abstract available


  269. GLASSNER K, Malaty HM, Abraham BP
    Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:998-1003.
    PubMed     Text format     Abstract available


  270. HEIDA A, Park KT, van Rheenen PF
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.
    Inflamm Bowel Dis. 2017;23:894-902.
    PubMed     Text format     Abstract available


  271. NGUYEN GC, Boland K, Afif W, Bressler B, et al
    Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:858-865.
    PubMed     Text format     Abstract available


  272. YADAV A, Foromera J, Feuerstein I, Falchuk KR, et al
    Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:853-857.
    PubMed     Text format     Abstract available


  273. BERRY AC, Dholaria K, Czul-Gurdian F, Forster E, et al
    Relationship Between Patient Knowledge and Medication Adherence in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E39-E40.
    PubMed     Text format    


  274. HOPKINS CWP, Butt HS, Moulton CD
    Beyond Efficacy: The Acceptability of Antidepressant Treatment to Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E38.
    PubMed     Text format    


    May 2017
  275. DAN A, Boutros M, Nedjar H, Kopylov U, et al
    Cost of Ulcerative Colitis in Quebec, Canada: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2017 May 29. doi: 10.1097/MIB.0000000000001147.
    PubMed     Text format     Abstract available


  276. BUISSON A, Gonzalez F, Poullenot F, Nancey S, et al
    Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001140.
    PubMed     Text format     Abstract available


  277. LOPEZ RN, Evans HM, Appleton L, Bishop J, et al
    Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001138.
    PubMed     Text format     Abstract available


  278. FEAGINS LA, Waljee A, Hou JK, Gu P, et al
    Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001145.
    PubMed     Text format     Abstract available


  279. CHAO K, Wang X, Cao Q, Qian J, et al
    Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001148.
    PubMed     Text format     Abstract available


  280. BORREN NZ, Conway G, Tan W, Andrews E, et al
    Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001133.
    PubMed     Text format     Abstract available


  281. VALER P, Algaba A, Santos D, Fuentes ME, et al
    Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001081.
    PubMed     Text format     Abstract available


  282. FATTAHI MR, Malek-Hosseini SA, Sivandzadeh GR, Safarpour AR, et al
    Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001105.
    PubMed     Text format     Abstract available


  283. NGUYEN GC, Boland K, Afif W, Bressler B, et al
    Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 15. doi: 10.1097/MIB.0000000000001152.
    PubMed     Text format     Abstract available


  284. YADAV A, Foromera J, Feuerstein I, Falchuk KR, et al
    Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 15. doi: 10.1097/MIB.0000000000001153.
    PubMed     Text format     Abstract available


  285. JULSGAARD M, Hvas CL, Gearry RB, Vestergaard T, et al
    Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001136.
    PubMed     Text format     Abstract available


  286. RESTALL GJ, Simms AM, Walker JR, Haviva C, et al
    Coping with Inflammatory Bowel Disease: Engaging with Information to Inform Health-Related Decision Making in Daily Life.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001141.
    PubMed     Text format     Abstract available


  287. KELLY OB, Donnell SO, Stempak JM, Steinhart AH, et al
    Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001126.
    PubMed     Text format     Abstract available


  288. JEGANATHAN J, Lee CH, Rahme A, Tiao DK, et al
    Pediatric-to-adult Transition and Medication Adherence in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001114.
    PubMed     Text format     Abstract available


  289. GUNALTAY S, Repsilber D, Helenius G, Nyhlin N, et al
    Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001127.
    PubMed     Text format     Abstract available


  290. YANG H, Zhou W, Lv H, Wu D, et al
    The Association Between CMV Viremia or Endoscopic Features and Histopathological Characteristics of CMV Colitis in Patients with Underlying Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:814-821.
    PubMed     Text format     Abstract available


  291. THORLACIUS-USSING G, Schnack Nielsen B, Andersen V, Holmstrom K, et al
    Expression and Localization of miR-21 and miR-126 in Mucosal Tissue from Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:739-752.
    PubMed     Text format     Abstract available


  292. BURKE KE, Haviland MJ, Hacker MR, Shainker SA, et al
    Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:721-726.
    PubMed     Text format     Abstract available


  293. FOULON A, Dupas JL, Sabbagh C, Chevreau J, et al
    Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2017;23:712-720.
    PubMed     Text format     Abstract available


  294. NGUYEN GC, Murthy SK, Bressler B, Lam MCW, et al
    Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017;23:695-701.
    PubMed     Text format     Abstract available


  295. ASSA A, Bronsky J, Kolho KL, Zarubova K, et al
    Anti-TNFalpha Treatment After Surgical Resection for Crohn's Disease Is Effective Despite Previous Pharmacodynamic Failure.
    Inflamm Bowel Dis. 2017;23:791-797.
    PubMed     Text format     Abstract available


  296. DOTSON JL, Cho M, Bricker J, Kappelman MD, et al
    Race Differences in Initial Presentation, Early Treatment, and 1-year Outcomes of Pediatric Crohn's Disease: Results from the ImproveCareNow Network.
    Inflamm Bowel Dis. 2017;23:767-774.
    PubMed     Text format     Abstract available


  297. BROCHARD C, Siproudhis L, Leveque J, Grouin A, et al
    Factors Associated with Fecal Incontinence in Women of Childbearing Age with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:775-780.
    PubMed     Text format     Abstract available


  298. MA C, Fedorak RN, Kaplan GG, Dieleman LA, et al
    Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study.
    Inflamm Bowel Dis. 2017;23:833-839.
    PubMed     Text format     Abstract available


  299. WILSON A, Tirona RG, Kim RB
    CYP3A4 Activity is Markedly Lower in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:804-813.
    PubMed     Text format     Abstract available


    April 2017
  300. VAVRICKA SR, Gubler M, Gantenbein C, Spoerri M, et al
    Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.
    Inflamm Bowel Dis. 2017 Apr 27. doi: 10.1097/MIB.0000000000001109.
    PubMed     Text format     Abstract available


  301. MAGNUSSON MK, Strid H, Isaksson S, Simren M, et al
    The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001130.
    PubMed     Text format     Abstract available


  302. JACOB V, Crawford C, Cohen-Mekelburg S, Viladomiu M, et al
    Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001132.
    PubMed     Text format     Abstract available


  303. BUHL S, Steenholdt C, Rasmussen M, Borghede MK, et al
    Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001117.
    PubMed     Text format     Abstract available


  304. BARNES EL, Kochar B, Long MD, Kappelman MD, et al
    Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.
    Inflamm Bowel Dis. 2017 Apr 19. doi: 10.1097/MIB.0000000000001121.
    PubMed     Text format     Abstract available


  305. LIGHTNER AL, Tse CS, Quinn K, Bergquist JR, et al
    Preoperative Clostridium difficile Infection Does Not Affect Pouch Outcomes in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001122.
    PubMed     Text format     Abstract available


  306. MARTINEZ B, Dailey F, Almario CV, Keller MS, et al
    Patient Understanding of the Risks and Benefits of Biologic Therapies in Inflammatory Bowel Disease: Insights from a Large-scale Analysis of Social Media Platforms.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001110.
    PubMed     Text format     Abstract available


  307. ADAMS DW, Gurwara S, Silver HJ, Horst SN, et al
    Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001128.
    PubMed     Text format     Abstract available


  308. KOCHAR B, Long MD, Galanko J, Raffals LE, et al
    Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001115.
    PubMed     Text format     Abstract available


  309. VARNI JW, Shulman RJ, Self MM, Saeed SA, et al
    Patient Health Communication Mediating Effects Between Gastrointestinal Symptoms and Gastrointestinal Worry in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 6. doi: 10.1097/MIB.0000000000001077.
    PubMed     Text format     Abstract available


  310. BANASZKIEWICZ A, Gawronska A, Klincewicz B, Kofla-Dlubacz A, et al
    Immunogenicity of Pertussis Booster Vaccination in Children and Adolescents with Inflammatory Bowel Disease: A Controlled Study.
    Inflamm Bowel Dis. 2017 Apr 6. doi: 10.1097/MIB.0000000000001076.
    PubMed     Text format     Abstract available


  311. NAVANEETHAN U, Edminister T, Zhu X, Kommaraju K, et al
    Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E17.
    PubMed     Text format    


  312. KHAN A, Chandler M, Borum ML
    Patients with Inflammatory Bowel Disease May Use Electronic Communication with Their Physicians More Frequently Than Those Without Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E16.
    PubMed     Text format    


  313. STOCCO G, Martelossi S, Arrigo S, Barabino A, et al
    Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:628-634.
    PubMed     Text format     Abstract available


  314. TANDON P, James P, Cordeiro E, Mallick R, et al
    Diagnostic Accuracy of Blood-Based Tests and Histopathology for Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2017;23:551-560.
    PubMed     Text format     Abstract available


  315. LAN N, Shen B
    Endoscopic Stricturotomy with Needle Knife in the Treatment of Strictures from Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:502-513.
    PubMed     Text format     Abstract available


  316. RUBIN DT, Dubinsky MC, Martino S, Hewett KA, et al
    Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits.
    Inflamm Bowel Dis. 2017;23:494-501.
    PubMed     Text format     Abstract available


  317. KISTANGARI G, Lopez R, Shen B
    Frequency and Risk Factors of Clostridium difficile Infection in Hospitalized Patients With Pouchitis: A Population-based Study.
    Inflamm Bowel Dis. 2017;23:661-671.
    PubMed     Text format     Abstract available


  318. ZUNDLER S, Neurath MF
    Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:617-627.
    PubMed     Text format     Abstract available


  319. SHIYING W, Boyun S, Jianye Y, Wanjun Z, et al
    The Different Effects of VEGFA121 and VEGFA165 on Regulating Angiogenesis Depend on Phosphorylation Sites of VEGFR2.
    Inflamm Bowel Dis. 2017;23:603-616.
    PubMed     Text format     Abstract available


  320. SAEED MA, Ng GZ, Dabritz J, Wagner J, et al
    Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity.
    Inflamm Bowel Dis. 2017;23:593-602.
    PubMed     Text format     Abstract available


  321. GROSEN A, Kelsen J, Hvas CL, Bellaguarda E, et al
    The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure.
    Inflamm Bowel Dis. 2017;23:561-569.
    PubMed     Text format     Abstract available


  322. DE JONG M, van der Meulen-de Jong A, Romberg-Camps M, Degens J, et al
    Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD: MyIBDcoach.
    Inflamm Bowel Dis. 2017;23:485-493.
    PubMed     Text format     Abstract available


  323. HRADSKY O, Soucek O, Maratova K, Matyskova J, et al
    Supplementation with 2000 IU of Cholecalciferol Is Associated with Improvement of Trabecular Bone Mineral Density and Muscle Power in Pediatric Patients with IBD.
    Inflamm Bowel Dis. 2017;23:514-523.
    PubMed     Text format     Abstract available


  324. CHAUDHRY NA, Riverso M, Grajo JR, Moser PP, et al
    A Fixed Stricture on Routine Cross-sectional Imaging Predicts Disease-Related Complications and Adverse Outcomes in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:641-649.
    PubMed     Text format     Abstract available


  325. SHAH ED, Farida JP, Siegel CA, Chong K, et al
    Risk for Overall Infection with Anti-TNF and Anti-integrin Agents Used in IBD: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2017;23:570-577.
    PubMed     Text format     Abstract available


  326. BERNSTEIN CN, Burchill C, Targownik LE, Singh H, et al
    Maternal Infections That Would Warrant Antibiotic Use Antepartum or Peripartum Are Not a Risk Factor for the Development of IBD: A Population-Based Analysis.
    Inflamm Bowel Dis. 2017;23:635-640.
    PubMed     Text format     Abstract available


    March 2017
  327. NARULA N, Borges L, Steinhart AH, Colombel JF, et al
    Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011.
    Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001084.
    PubMed     Text format     Abstract available


  328. SUZUKI Y, Iida M, Ito H, Nishino H, et al
    2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial.
    Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001065.
    PubMed     Text format     Abstract available


  329. ANANTHAKRISHNAN AN, Donaldson T, Lasch K, Yajnik V, et al
    Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.
    Inflamm Bowel Dis. 2017 Mar 27. doi: 10.1097/MIB.0000000000001099.
    PubMed     Text format     Abstract available


  330. KAMMERLANDER H, Nielsen J, Kjeldsen J, Knudsen T, et al
    The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Mar 24. doi: 10.1097/MIB.0000000000001102.
    PubMed     Text format     Abstract available


  331. HATA K, Ishii H, Anzai H, Ishihara S, et al
    Preoperative Extraintestinal Manifestations Associated with Chronic Pouchitis in Japanese Patients with Ulcerative Colitis After Ileal Pouch-anal Anastomosis: A Retrospective Study.
    Inflamm Bowel Dis. 2017 Mar 24. doi: 10.1097/MIB.0000000000001094.
    PubMed     Text format     Abstract available


  332. ZULLOW S, Fazelat A, Farraye FA
    Central Serous Chorioretinopathy in a Patient with Ulcerative Colitis with Pouchitis on Budesonide-EC.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001091.
    PubMed     Text format    


  333. EL-MATARY W
    Indicators of Quality of Care in Inflammatory Bowel Disease: Seeking the Right Path for Patients.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001069.
    PubMed     Text format    


  334. KHAN N, Patel D, Shah Y, Lichtenstein G, et al
    A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001080.
    PubMed     Text format     Abstract available


  335. NGUYEN GC, Murthy SK, Bressler B, Lam MC, et al
    Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001068.
    PubMed     Text format     Abstract available


  336. NAVIGLIO S, Parentin F, Nider S, Rassu N, et al
    Ocular Involvement in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001079.
    PubMed     Text format     Abstract available


  337. ISHAK WW, Pan D, Steiner AJ, Feldman E, et al
    Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001060.
    PubMed     Text format     Abstract available


  338. ARORA Z, Mukewar S, Lopez R, Camino D, et al
    Etiopathogenesis of Nephrolithiasis in Ulcerative Colitis Patients with the Ileal Pouch Anal Anastomosis.
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001070.
    PubMed     Text format     Abstract available


  339. LIGHTNER AL, Mathis KL, Dozois EJ, Hahnsloser D, et al
    Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001061.
    PubMed     Text format     Abstract available


  340. KELSEN JR, Dawany N, Conrad M, Devoto M, et al
    Commentary on Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early-onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001028.
    PubMed     Text format    


  341. MACER BJ, Prady SL, Mikocka-Walus A
    Antidepressants in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001059.
    PubMed     Text format     Abstract available


  342. HUANG Z, Peng K, Li X, Zhao R, et al
    Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001058.
    PubMed     Text format     Abstract available


  343. SEXTON KA, Walker JR, Graff LA, Bernstein MT, et al
    Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:473-483.
    PubMed     Text format     Abstract available


  344. HUANG Y, Dalal S, Antonopoulos D, Hubert N, et al
    Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:366-378.
    PubMed     Text format     Abstract available


  345. CARLSEN K, Jakobsen C, Houen G, Kallemose T, et al
    Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2017;23:357-365.
    PubMed     Text format     Abstract available


  346. POOJARY P, Saha A, Chauhan K, Simoes P, et al
    Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
    Inflamm Bowel Dis. 2017;23:347-356.
    PubMed     Text format     Abstract available


  347. TARGOWNIK LE, Tennakoon A, Leung S, Lix LM, et al
    Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis.
    Inflamm Bowel Dis. 2017;23:409-420.
    PubMed     Text format     Abstract available


  348. ZUNDLER S, Fischer A, Schillinger D, Binder MT, et al
    The alpha4beta1 Homing Pathway Is Essential for Ileal Homing of Crohn's Disease Effector T Cells In Vivo.
    Inflamm Bowel Dis. 2017;23:379-391.
    PubMed     Text format     Abstract available


  349. CARLSEN K, Haddad N, Gordon J, Phan BL, et al
    Self-efficacy and Resilience Are Useful Predictors of Transition Readiness Scores in Adolescents with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:341-346.
    PubMed     Text format     Abstract available


  350. SEINEN ML, van Asseldonk DP, de Boer NK, Bouma G, et al
    Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.
    Inflamm Bowel Dis. 2017;23:448-452.
    PubMed     Text format     Abstract available


  351. LOPETUSO LR, Jia R, Wang XM, Jia LG, et al
    Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis.
    Inflamm Bowel Dis. 2017;23:392-403.
    PubMed     Text format     Abstract available


  352. COWARD S, Kuenzig ME, Hazlewood G, Clement F, et al
    Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
    Inflamm Bowel Dis. 2017;23:461-472.
    PubMed     Text format     Abstract available


  353. GHOSH S, Louis E, Beaugerie L, Bossuyt P, et al
    Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:333-340.
    PubMed     Text format     Abstract available


  354. LU C, Gui X, Chen W, Fung T, et al
    Ultrasound Shear Wave Elastography and Contrast Enhancement: Effective Biomarkers in Crohn's Disease Strictures.
    Inflamm Bowel Dis. 2017;23:421-430.
    PubMed     Text format     Abstract available


  355. FAUBION WA, Dubinsky M, Ruemmele FM, Escher J, et al
    Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:453-460.
    PubMed     Text format     Abstract available


  356. HUANG Z, Chao K, Li M, Zhi M, et al
    Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
    Inflamm Bowel Dis. 2017;23:440-447.
    PubMed     Text format     Abstract available


    February 2017
  357. CARLSEN K, Jakobsen C, Houen G, Kallemose T, et al
    Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001026.
    PubMed     Text format     Abstract available


  358. POOJARY P, Saha A, Chauhan K, Simoes P, et al
    Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001041.
    PubMed     Text format     Abstract available


  359. HUANG Y, Dalal S, Antonopoulos D, Hubert N, et al
    Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001027.
    PubMed     Text format     Abstract available


  360. BRANDSE JF, Mould D, Smeekes O, Ashruf Y, et al
    A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Feb 10. doi: 10.1097/MIB.0000000000001043.
    PubMed     Text format     Abstract available


  361. KOPYLOV U, Ron Y, Avni-Biron I, Koslowsky B, et al
    Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience.
    Inflamm Bowel Dis. 2017 Feb 7. doi: 10.1097/MIB.0000000000001039.
    PubMed     Text format     Abstract available


  362. RODRIGUEZ-PALACIOS A, Corridoni D, Di Stefano G, Di Martino L, et al
    O-014 Bacterial Sensor NOD2 Deletion Causes Th2-Inflammatory Bowel Disease Improvement Without Inducing Acute Metatranscriptomic Dysbiosis in Mice.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S5.
    PubMed     Text format     Abstract available


  363. HABERMAN Y, Ben-Shoshan M, Di-Segni A, Dexheimer P, et al
    O-009 Long ncRNA Landscape in the Ileum of Treatment Naive Early Onset Crohn Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S3-S4.
    PubMed     Text format     Abstract available


  364. KIM ES, Jang BI, Kim KO, Kim EY, et al
    O-007 Impact of Education on School Nurses' Knowledge of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S3.
    PubMed     Text format     Abstract available


  365. EL-MATARY W, Samson C, Crim A, Ali S, et al
    O-006 Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multi-Center North American Experience.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S2-S3.
    PubMed     Text format     Abstract available


  366. SHAKHNOVICH V, Van Haandel L, Becker M, Funk R, et al
    O-005 Combination Therapy with Methotrexate Does Not Change Infliximab Pharmacokinetics in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S2.
    PubMed     Text format     Abstract available


  367. DUPONT-LUCAS C, Grandjean-Blanchet C, Leduc B, Tripcovici M, et al
    Prevalence and Risk Factors for Symptoms of Methotrexate Intolerance in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:298-303.
    PubMed     Text format     Abstract available


  368. ALEXAKIS C, Saxena S, Chhaya V, Cecil E, et al
    Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
    Inflamm Bowel Dis. 2017 Feb 1. doi: 10.1097/MIB.0000000000001031.
    PubMed     Text format     Abstract available


  369. MAGRO F, Dias CC, Coelho R, Santos PM, et al
    Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling Outcomes.
    Inflamm Bowel Dis. 2017;23:289-297.
    PubMed     Text format     Abstract available


  370. ZAYYANI NR, Malaty HM, Graham DY
    Increasing Incidence of Crohn's Disease with Familial Clustering in the Kingdom of Bahrain: A 25-Year Population-based Study.
    Inflamm Bowel Dis. 2017;23:304-309.
    PubMed     Text format     Abstract available


  371. DIEDEREN K, de Ridder L, van Rheenen P, Wolters VM, et al
    Complications and Disease Recurrence After Primary Ileocecal Resection in Pediatric Crohn's Disease: A Multicenter Cohort Analysis.
    Inflamm Bowel Dis. 2017;23:272-282.
    PubMed     Text format     Abstract available


  372. VELONIAS G, Conway G, Andrews E, Garber JJ, et al
    Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:283-288.
    PubMed     Text format     Abstract available


  373. LI XH, Sun CH, Mao R, Huang SY, et al
    Diffusion-weighted MRI Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn's Disease: Results from an Observational Study.
    Inflamm Bowel Dis. 2017;23:244-253.
    PubMed     Text format     Abstract available


    January 2017
  374. RUAN J, Chen Y, Zhou Y
    Development and Validation of a Questionnaire to Assess the Quality of Life in Patients with Inflammatory Bowel Disease in Mainland China.
    Inflamm Bowel Dis. 2017 Jan 26. doi: 10.1097/MIB.0000000000001024.
    PubMed     Text format     Abstract available


  375. FIORINO G, Manetti N, Armuzzi A, Orlando A, et al
    The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000000995.
    PubMed     Text format     Abstract available


  376. KUCHARZIK T, Lemmnitz G, Abels C, Maaser C, et al
    Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001000.
    PubMed     Text format     Abstract available


  377. ABDALLA MI, Sandler RS, Kappelman MD, Martin CF, et al
    Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001017.
    PubMed     Text format     Abstract available


  378. QIN X
    Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001010.
    PubMed     Text format    


  379. KORELITZ BI, Shamah S
    The Ileitis of Ulcerative Colitis. Why Is It Not Crohn's Disease?
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001006.
    PubMed     Text format    


  380. SCHREINER P, Biedermann L, Rossel JB, Rogler G, et al
    Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001012.
    PubMed     Text format     Abstract available


  381. COENEN S, Weyts E, Jorissen C, De Munter P, et al
    Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001013.
    PubMed     Text format     Abstract available


  382. CHEN Y, Furuya-Kanamori L, Doi SA, Ananthakrishnan AN, et al
    Clostridium difficile Infection and Risk of Colectomy in Patients with Inflammatory Bowel Disease: A Bias-adjusted Meta-analysis.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000000998.
    PubMed     Text format     Abstract available


  383. LEWIS JD, Albenberg L, Lee D, Kratz M, et al
    The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001009.
    PubMed     Text format     Abstract available


  384. PICORARO J, Winberry G, Siegel CA, El-Matary W, et al
    Premedication Use Before Infliximab Administration: A Cross-sectional Analysis.
    Inflamm Bowel Dis. 2017;23:174-180.
    PubMed     Text format     Abstract available


  385. BETTENWORTH D, Gustavsson A, Atreja A, Lopez R, et al
    A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:133-142.
    PubMed     Text format     Abstract available


  386. ROBLIN X, Duru G, Williet N, Del Tedesco E, et al
    Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:126-132.
    PubMed     Text format     Abstract available


  387. GUMIDYALA AP, Plevinsky JM, Poulopoulos N, Kahn SA, et al
    What Teens Do Not Know Can Hurt Them: An Assessment of Disease Knowledge in Adolescents and Young Adults with IBD.
    Inflamm Bowel Dis. 2017;23:89-96.
    PubMed     Text format     Abstract available


  388. LIE MR, Kreijne JE, van der Woude CJ
    Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:75-81.
    PubMed     Text format     Abstract available


  389. COELHO R, Ribeiro H, Maconi G
    Bowel Thickening in Crohn's Disease: Fibrosis or Inflammation? Diagnostic Ultrasound Imaging Tools.
    Inflamm Bowel Dis. 2017;23:23-34.
    PubMed     Text format     Abstract available


  390. YARUR AJ, Quintero MA, Jain A, Czul F, et al
    Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:158-164.
    PubMed     Text format     Abstract available


  391. SANDS BE, Sandborn WJ, Van Assche G, Lukas M, et al
    Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy.
    Inflamm Bowel Dis. 2017;23:97-106.
    PubMed     Text format     Abstract available


  392. RISPO A, Imperatore N, Testa A, Mainenti P, et al
    Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index.
    Inflamm Bowel Dis. 2017;23:143-151.
    PubMed     Text format     Abstract available


  393. SAKURAI T, Kashida H, Komeda Y, Nagai T, et al
    Stress Response Protein RBM3 Promotes the Development of Colitis-associated Cancer.
    Inflamm Bowel Dis. 2017;23:57-65.
    PubMed     Text format     Abstract available


  394. RAO BB, Click BH, Koutroubakis IE, Ramos Rivers C, et al
    The Cost of Crohn's Disease: Varied Health Care Expenditure Patterns Across Distinct Disease Trajectories.
    Inflamm Bowel Dis. 2017;23:107-115.
    PubMed     Text format     Abstract available


  395. VAN DER SLOOT KW, Joshi AD, Bellavance DR, Gilpin KK, et al
    Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease.
    Inflamm Bowel Dis. 2017;23:82-88.
    PubMed     Text format     Abstract available


  396. HOU JK, Gasche C, Drazin NZ, Weaver SA, et al
    Assessment of Gaps in Care and the Development of a Care Pathway for Anemia in Patients with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2017;23:35-43.
    PubMed     Text format     Abstract available


  397. HERFARTH HH, Jackson S, Schliebe BG, Martin C, et al
    Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.
    Inflamm Bowel Dis. 2017;23:14-22.
    PubMed     Text format     Abstract available


    December 2016
  398. NGUYEN GC, Bernstein CN, Benchimol EI
    Risk of Surgery and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000993.
    PubMed     Text format     Abstract available


  399. RUBIN DT, Feld LD, Goeppinger SR, Margolese J, et al
    The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000994.
    PubMed     Text format     Abstract available


  400. HOU JK, Kramer JR, Richardson P, Sansgiry S, et al
    Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000001003.
    PubMed     Text format     Abstract available


  401. FRIEDMAN S, Larsen PV, Fedder J, Norgard BM, et al
    The Efficacy of Assisted Reproduction in Women with Inflammatory Bowel Disease and the Impact of Surgery-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000996.
    PubMed     Text format     Abstract available


  402. SIVA S, Rubin DT, Gulotta G, Wroblewski K, et al
    Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  403. TAHARA T, Hirata I, Nakano N, Nagasaka M, et al
    Comprehensive DNA Methylation Profiling of Inflammatory Mucosa in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  404. GRACIE DJ, Ford AC
    Ongoing Symptoms in Ulcerative Colitis Patients in Remission: Irritable Bowel Syndrome or Gastrointestinal Symptoms in the Absence of Inflammation?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  405. HUANG C, De Ravin SS, Paul AR, Heller T, et al
    Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Inflamm Bowel Dis. 2016;22:2794-2801.
    PubMed     Text format     Abstract available


    November 2016
  406. CUI DJ, Yang XL, Hu M, Yang LC, et al
    Effects of Preoperative Methotrexate on Complications After Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  407. ISHIKAWA D, Sasaki T, Osada T, Kuwahara-Arai K, et al
    Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  408. ROBINSON AM, Gondalia SV, Karpe AV, Eri R, et al
    Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  409. HUANG C, De Ravin SS, Paul AR, Heller T, et al
    Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  410. TAKESHITA K, Mizuno S, Mikami Y, Sujino T, et al
    A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  411. CALDERA F, Hayney MS
    Barriers to Administration of Herpes Zoster Immunization in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:E44.
    PubMed     Text format    


  412. MOTTET C, Schoepfer AM, Juillerat P, Cosnes J, et al
    Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2733-2747.
    PubMed     Text format     Abstract available


  413. HASHASH JG, Sigal R, Wein-Levy P, Szigethy EM, et al
    Inflammatory Bowel Disease (IBD) Connect: A Novel Volunteer Program for Hospitalized Patients with IBD and Their Families.
    Inflamm Bowel Dis. 2016;22:2748-2753.
    PubMed     Text format     Abstract available


  414. GIANOTTI RJ, Moss AC
    The Use and Efficacy of Fecal Microbiota Transplantation for Refractory Clostridium difficile in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2704-2710.
    PubMed     Text format     Abstract available


  415. REICH J, Guo L, Hall J, Tran A, et al
    A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2678-2687.
    PubMed     Text format     Abstract available


  416. COLLIJ V, Festen EA, Alberts R, Weersma RK, et al
    Drug Repositioning in Inflammatory Bowel Disease Based on Genetic Information.
    Inflamm Bowel Dis. 2016;22:2562-2570.
    PubMed     Text format     Abstract available


  417. TEW GA, Jones K, Mikocka-Walus A
    Physical Activity Habits, Limitations, and Predictors in People with Inflammatory Bowel Disease: A Large Cross-sectional Online Survey.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    October 2016
  418. CHOY MC, Visvanathan K, De Cruz P
    An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  419. BARNES EL, Burakoff R
    New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  420. PALONE F, Vitali R, Cucchiara S, Mennini M, et al
    Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  421. CHEN SW, Wang PY, Liu YC, Sun L, et al
    Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  422. CANEPARO V, Pastorelli L, Pisani LF, Bruni B, et al
    Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  423. JONEFJALL B, Ohman L, Simren M, Strid H, et al
    IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  424. QIN X
    Perinuclear Antineutrophil Cytoplasmic Antibody with a Large Portion Being Anti-beta-Glucuronidase, May Have Played a Causative Role in the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  425. ZITTAN E, Milgrom R, Ma GW, Wong-Chong N, et al
    Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  426. COTE-DAIGNEAULT J, Peerani F, MacMahon E, Delaporte E, et al
    Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  427. CONRAD MA, Stein RE, Maxwell EC, Albenberg L, et al
    Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  428. SEDGHI S, Barreau F, Morilla I, Montcuquet N, et al
    Increased Proliferation of the Ileal Epithelium as a Remote Effect of Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  429. TALABUR HORJE CS, Meijer J, Rovers L, van Lochem EG, et al
    Prevalence of Upper Gastrointestinal Lesions at Primary Diagnosis in Adults with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:E33-4.
    PubMed     Text format    


  430. NOBEL T, Khaitov S, Greenstein AJ
    Controversies in J Pouch Surgery for Ulcerative Colitis: A Focus on Handsewn Versus Stapled Anastomosis.
    Inflamm Bowel Dis. 2016;22:2302-9.
    PubMed     Text format     Abstract available


  431. ABDUL-BAKI H, Greer JB, Binion DG, Kermanshahi TR, et al
    IBD LIVE Case Series-Case 5: The Many Faces of Cytomegalovirus in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2245-54.
    PubMed     Text format    


  432. BARNES EL, Beery RM, Schulman AR, McCarthy EP, et al
    Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database.
    Inflamm Bowel Dis. 2016;22:2229-37.
    PubMed     Text format     Abstract available


  433. LEVY RL, van Tilburg MA, Langer SL, Romano JM, et al
    Effects of a Cognitive Behavioral Therapy Intervention Trial to Improve Disease Outcomes in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2134-48.
    PubMed     Text format     Abstract available


  434. SINGH N, Rabizadeh S, Jossen J, Pittman N, et al
    Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2121-6.
    PubMed     Text format     Abstract available


  435. GOFFIN L, Fagagnini S, Vicari A, Mamie C, et al
    Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis.
    Inflamm Bowel Dis. 2016;22:2041-57.
    PubMed     Text format     Abstract available


    August 2016
  436. HAMILTON MJ, Makrauer FM, Golden K, Wang H, et al
    Prospective Evaluation of Terminal Ileitis in a Surveillance Population of Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  437. FISCHER M, Kao D, Kelly C, Kuchipudi A, et al
    Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  438. KOPYLOV U, Boucher G, Waterman M, Rivers CR, et al
    Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  439. LIM TY, Pavlidis P, Gulati S, Pirani T, et al
    Vedolizumab in Inflammatory Bowel Disease Associated with Autoimmune Liver Disease Pre- and Postliver Transplantation: A Case Series.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  440. BENCHIMOL EI, Manuel DG, Mojaverian N, Mack DR, et al
    Health Services Utilization, Specialist Care, and Time to Diagnosis with Inflammatory Bowel Disease in Immigrants to Ontario, Canada: A Population-Based Cohort Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  441. ASHTON JJ, Andreoletti G, Coelho T, Haggarty R, et al
    Identification of Variants in Genes Associated with Single-gene Inflammatory Bowel Disease by Whole-exome Sequencing.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  442. GLOVER LE, Fennimore B, Wingfield M
    Inflammatory Bowel Disease: Influence and Implications in Reproduction.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  443. LEE WJ, Briars L, Lee TA, Calip GS, et al
    Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  444. HASOSAH M, Matrafi A, Jastaniah W, Alsahafi A, et al
    Pediatric Inflammatory Bowel Disease and Hereditary Hemolytic Anemia: A Retrospective Analysis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  445. MCDANIEL DK, Eden K, Ringel VM, Allen IC, et al
    Emerging Roles for Noncanonical NF-kappaB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  446. GUERRERIO AL, Frischmeyer-Guerrerio PA, Huang C, Wu Y, et al
    Increased Prevalence of Inflammatory Bowel Disease in Patients with Mutations in Genes Encoding the Receptor Subunits for TGFbeta.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  447. JACKSON WE, Achkar JP, Macaron C, Lee L, et al
    The Significance of Sessile Serrated Polyps in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  448. LI R, Zheng J, Jiang M, Liu Y, et al
    Increased Digestive Proteases and Decreased beta-Glucuronidase in Feces of Rats Treated with Sucralose and Saccharin-Another Critical Evidence That These Dietary Chemicals May Be Important Causative Factors for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:E29-30.
    PubMed     Text format    


  449. TAO Z, Qin Z
    Can Statins Be Used in Patients with Inflammatory Bowel Disease Regularly?
    Inflamm Bowel Dis. 2016;22:E28-9.
    PubMed     Text format    


  450. MATTHIS AL, Zhang B, Denson LA, Yacyshyn BR, et al
    Importance of the Evaluation of N-Acetyltransferase Enzyme Activity Prior to 5-Aminosalicylic Acid Medication for Ulcerative Colitis.
    Inflamm Bowel Dis. 2016;22:1793-802.
    PubMed     Text format     Abstract available


  451. NG SC, Leung WK, Shi HY, Li MK, et al
    Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong.
    Inflamm Bowel Dis. 2016;22:1954-60.
    PubMed     Text format     Abstract available


  452. GOVANI SM, Wiitala WL, Stidham RW, Saini SD, et al
    Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:1923-8.
    PubMed     Text format     Abstract available


  453. REIGADA LC, Satpute A, Hoogendoorn CJ, Cohen BH, et al
    Patient-reported Anxiety: A Possible Predictor of Pediatric Inflammatory Bowel Disease Health Care Use.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  454. SEVERS M, Zuithoff PN, Mangen MJ, van der Valk ME, et al
    Assessing Self-reported Medication Adherence in Inflammatory Bowel Disease: A Comparison of Tools.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  455. SU HY, Gupta V, Day AS, Gearry RB, et al
    Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  456. HOU JK, Feagins LA, Waljee AK
    Characteristics and Behavior of Elderly-onset Inflammatory Bowel Disease: A Multi-center US Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  457. VAN ASSELDONK DP, Jharap B, Verheij J, den Hartog G, et al
    The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  458. KOCHHAR G, Singh T, Dust H, Lopez R, et al
    Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation.
    Inflamm Bowel Dis. 2016;22:1670-8.
    PubMed     Text format     Abstract available


  459. ABDUL SULTAN A, West J, Ban L, Humes D, et al
    Adverse Pregnancy Outcomes Among Women with Inflammatory Bowel Disease: A Population-Based Study from England.
    Inflamm Bowel Dis. 2016;22:1621-30.
    PubMed     Text format     Abstract available


  460. DOTSON JL, Falaiye T, Bricker JB, Strople J, et al
    North American Pediatric Gastroenterology Fellowship Needs Assessment in Inflammatory Bowel Disease: Trainee and Program Director Perspectives.
    Inflamm Bowel Dis. 2016;22:1616-20.
    PubMed     Text format     Abstract available


  461. COHEN BL, Ha C, Ananthakrishnan AN, Rieder F, et al
    State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National Survey.
    Inflamm Bowel Dis. 2016;22:1609-15.
    PubMed     Text format     Abstract available


  462. TOM MR, Li J, Ueno A, Fort Gasia M, et al
    Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:1596-608.
    PubMed     Text format     Abstract available


  463. AFZALI A, Cross RK
    Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  464. BESSISSOW T, Le NH, Rollet K, Afif W, et al
    Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  465. MITSUHASHI S, Feldbrugge L, Csizmadia E, Mitsuhashi M, et al
    Luminal Extracellular Vesicles (EVs) in Inflammatory Bowel Disease (IBD) Exhibit Proinflammatory Effects on Epithelial Cells and Macrophages.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  466. SCAIOLI E, Digby RJ, Belluzzi A
    Different Cutoff Levels of Fecal Calprotectin to Predict Clinical Relapse in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  467. CONROY G, Clerc-Urmes I, Allen PB, Baumann C, et al
    What Proportion of Patients With Inflammatory Bowel Disease Want to Stop Infliximab Therapy?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  468. LIMDI JK
    Rectal Therapy in Ulcerative Colitis: Science and Sensitivity.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  469. SMOLINSKA S, Groeger D, Perez NR, Schiavi E, et al
    Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  470. ALOI M, D'Arcangelo G, Bramuzzo M, Gasparetto M, et al
    Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  471. PAVLIDIS P, Stamoulos P, Abdulrehman A, Kerr P, et al
    Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  472. RESTALL GJ, Simms AM, Walker JR, Graff LA, et al
    Understanding Work Experiences of People with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  473. GREN ST, Grip O
    Role of Monocytes and Intestinal Macrophages in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  474. LI J, Ueno A, Fort Gasia M, Luider J, et al
    Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  475. ANDREWS C, McLean MH, Durum SK
    Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  476. SUBRAMANIAN S, Asher R, Weston W, Rimmer M, et al
    Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  477. LOPETUSO LR, Ianiro G, Scaldaferri F, Cammarota G, et al
    Gut Virome and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  478. HUPPERTZ-HAUSS G, Lie Hoivik M, Jelsness-Jorgensen LP, Henriksen M, et al
    Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  479. REININK AR, Lee TC, Higgins PD
    Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  480. RIEDER F, Cohen BL, Dotson JL, Bewtra M, et al
    Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease-Promoting Improvement of Inflammatory Bowel Disease Education in the United States.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  481. HOPKINS CW, Moulton CD
    Is it Premature to Advocate Systematic Psychological Screening for Patients with Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  482. DEGRUTTOLA AK, Low D, Mizoguchi A, Mizoguchi E, et al
    Current Understanding of Dysbiosis in Disease in Human and Animal Models.
    Inflamm Bowel Dis. 2016;22:1137-50.
    PubMed     Text format     Abstract available


  483. DONEGAN A, Boyle B, Crandall W, Dotson JL, et al
    Connecting Families: A Pediatric IBD Center's Development and Implementation of a Volunteer Parent Mentor Program.
    Inflamm Bowel Dis. 2016;22:1151-6.
    PubMed     Text format     Abstract available


  484. GREENUP AJ, Bressler B, Rosenfeld G
    Medical Imaging in Small Bowel Crohn's Disease-Computer Tomography Enterography, Magnetic Resonance Enterography, and Ultrasound: "Which One Is the Best for What?".
    Inflamm Bowel Dis. 2016;22:1246-61.
    PubMed     Text format     Abstract available


  485. GANZ ML, Sugarman R, Wang R, Hansen BB, et al
    The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey.
    Inflamm Bowel Dis. 2016;22:1032-41.
    PubMed     Text format     Abstract available


  486. CALABRESE E, Maaser C, Zorzi F, Kannengiesser K, et al
    Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts.
    Inflamm Bowel Dis. 2016;22:1168-83.
    PubMed     Text format     Abstract available


  487. SEHGAL P, Colombel JF, Narula N
    Adverse Events During Anti-TNFalpha Therapies in IBD (Excluding Infections and Malignancies): When to Stop, Continue, or Switch Therapies.
    Inflamm Bowel Dis. 2016;22:1239-45.
    PubMed     Text format     Abstract available


  488. SAAD AM, Czul F, Sakuraba A, Rubin DT, et al
    Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1027-31.
    PubMed     Text format     Abstract available


  489. FLASAR MH, Chao J, Ozbay AB, Skup M, et al
    Biological and Immunomodulator Use in Crohn's Disease in a Medicaid Population.
    Inflamm Bowel Dis. 2016;22:1056-64.
    PubMed     Text format     Abstract available


  490. CHACHU KA, Osterman MT
    How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBD.
    Inflamm Bowel Dis. 2016;22:1262-74.
    PubMed     Text format     Abstract available


  491. HAYASHI R, Tsuchiya K, Fukushima K, Horita N, et al
    Reduced Human alpha-defensin 6 in Noninflamed Jejunal Tissue of Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1119-28.
    PubMed     Text format     Abstract available


  492. INOKUCHI T, Kato J, Hiraoka S, Takashima S, et al
    Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1078-85.
    PubMed     Text format     Abstract available


  493. CHEN ML, Sundrud MS
    Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:1157-67.
    PubMed     Text format     Abstract available


  494. GALE G, Sigurdsson GV, Ostman S, Malmborg P, et al
    Does Crohn's Disease with Concomitant Orofacial Granulomatosis Represent a Distinctive Disease Subtype?
    Inflamm Bowel Dis. 2016;22:1071-7.
    PubMed     Text format     Abstract available


  495. LIMKETKAI BN, Parian AM, Shah ND, Colombel JF, et al
    Short Bowel Syndrome and Intestinal Failure in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1209-18.
    PubMed     Text format     Abstract available


  496. MURAWSKA N, Fabisiak A, Fichna J
    Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases: Pathophysiology, Diagnosis, and Treatment.
    Inflamm Bowel Dis. 2016;22:1198-208.
    PubMed     Text format     Abstract available


  497. WRIGHT EK, Kamm MA, De Cruz P, Hamilton AL, et al
    Comparison of Fecal Inflammatory Markers in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1086-94.
    PubMed     Text format     Abstract available


    April 2016
  498. MIKOCKA-WALUS A, Knowles SR, Keefer L, Graff L, et al
    Addressing Psychological Needs of Individuals with Inflammatory Bowel Disease Is Necessary.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  499. REGUEIRO MD, McAnallen SE, Greer JB, Perkins SE, et al
    The Inflammatory Bowel Disease Specialty Medical Home: A New Model of Patient-centered Care.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  500. GARRITY-PARK MM, Loftus EV Jr, Bryant SC, Smyrk TC, et al
    A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  501. SUN L, Wang W, Xiao W, Yang H, et al
    The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  502. STEENHOLDT C, Bendtzen K, Brynskov J, Ainsworth MA, et al
    Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  503. CASALS-SEOANE F, Chaparro M, Mate J, Gisbert JP, et al
    Clinical Course of Bone Metabolism Disorders in Patients with Inflammatory Bowel Disease: A 5-Year Prospective Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  504. BIRIMBERG-SCHWARTZ L, Wilson DC, Kolho KL, Karolewska-Bochenek K, et al
    pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  505. HEYBELI C
    The Complement System and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  506. RAO K, Higgins PD
    Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  507. NGUYEN GC, Croitoru K, Silverberg MS, Steinhart AH, et al
    Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  508. YAMMINE S, Nyilas S, Casaulta C, Schibli S, et al
    Function and Ventilation of Large and Small Airways in Children and Adolescents with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  509. OPSTELTEN JL, Leenders M, Dik VK, Chan SS, et al
    Dairy Products, Dietary Calcium, and Risk of Inflammatory Bowel Disease: Results From a European Prospective Cohort Investigation.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  510. WEISSHOF R, Ungar B, Blatt A, Dahan A, et al
    Anti-infliximab Antibodies with Neutralizing Capacity in Patients with Inflammatory Bowel Disease: Distinct Clinical Implications Revealed by a Novel Assay.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  511. COBURN LA, Horst SN, Allaman MM, Brown CT, et al
    L-Arginine Availability and Metabolism Is Altered in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  512. JOHNSON DH, Taylor WR, Aboelsoud MM, Foote PH, et al
    DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  513. JANECKE AR, Heinz-Erian P, Muller T
    Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease-Associated Diarrhea.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  514. YAGI S, Abe M, Yamashita M, Mori K, et al
    Carbonic Anhydrate I Epitope Peptide Improves Inflammation in a Murine Model of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  515. MANETTI N, Bagnoli S, Rogai F, Bonanomi AG, et al
    Disease Course and Colectomy Rate of Ulcerative Colitis: A Follow-up Cohort Study of a Referral Center in Tuscany.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  516. BIANCHERI P, Foster MR, Fyfe MC, MacDonald TT, et al
    Effect of Narrow Spectrum Versus Selective Kinase Inhibitors on the Intestinal Proinflammatory Immune Response in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  517. AL-HUSSAINI A, El Mouzan M, Hasosah M, Al-Mehaidib A, et al
    Clinical Pattern of Early-Onset Inflammatory Bowel Disease in Saudi Arabia: A Multicenter National Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  518. LI J, Wei Z, Chang X, Cardinale CJ, et al
    Pathway-based Genome-wide Association Studies Reveal the Association Between Growth Factor Activity and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  519. MESTROVIC T
    Leveling the Human Microbiota Playing Field: A Rederivation of Gut Bacteria to Human Cells Ratio in Physiological Conditions and in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  520. WU W, Chen F, Liu Z, Cong Y, et al
    Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  521. QIN X
    How Sugar and Soft Drinks Are Related to Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  522. HORJUS TALABUR HORJE CS, Meijer J, Rovers L, van Lochem EG, et al
    Prevalence of Upper Gastrointestinal Lesions at Primary Diagnosis in Adults with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  523. HERRERA-DEGUISE C, Casellas F, Robles V, Navarro E, et al
    Iron Deficiency in the Absence of Anemia Impairs the Perception of Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  524. AFZALI A, Park CJ, Zhu K, Hu JK, et al
    Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  525. DEVLIN SM, Melmed GY, Irving PM, Rubin DT, et al
    Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  526. WASAN SK, Zullow S, Berg A, Cheifetz AS, et al
    Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose Immunosuppression.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  527. BUCHNER AM, Lichtenstein GR
    How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems.
    Inflamm Bowel Dis. 2016;22:1010-9.
    PubMed     Text format     Abstract available


  528. GILS A, Van Stappen T, Dreesen E, Storme R, et al
    Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples.
    Inflamm Bowel Dis. 2016;22:969-75.
    PubMed     Text format     Abstract available


  529. DUBINSKY MC, Rosh J, Faubion WA Jr, Kierkus J, et al
    Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:886-93.
    PubMed     Text format     Abstract available


  530. KAUR M, Panikkath D, Yan X, Liu Z, et al
    Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway.
    Inflamm Bowel Dis. 2016;22:862-9.
    PubMed     Text format     Abstract available


  531. VERGARA M, Sicilia B, Prieto L, Casellas F, et al
    Development and Validation of the Short Crohn's Disease Work Disability Questionnaire.
    Inflamm Bowel Dis. 2016;22:955-62.
    PubMed     Text format     Abstract available


  532. JUNG ES, Cheon JH, Lee JH, Park SJ, et al
    HLA-C*01 is a Risk Factor for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:796-806.
    PubMed     Text format     Abstract available


  533. MA C, Beilman CL, Huang VW, Fedorak DK, et al
    Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2016;22:870-9.
    PubMed     Text format     Abstract available


    March 2016
  534. QIN X
    Is Colonic Crohn's Disease More Closely Related to Ulcerative Colitis or Crohn's Disease by Nature?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  535. QIN X
    The Possible Link Between Artificial Sweeteners Such as Saccharin and Sucralose and Inflammatory Bowel Disease Deserves Further Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  536. GEISZ M, Ha C, Kappelman MD, Martin CF, et al
    Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  537. BRANDSE JF, Bennink RJ, van Eeden S, Lowenberg M, et al
    Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  538. KOH SZ, Zaghiyan KN, Li Q, Rabizadeh S, et al
    Clinical Factors Associated with the Development of Crohn's Disease in Inflammatory Bowel Disease-unclassified Patients Undergoing Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  539. TYLER AD, Kirsch R, Milgrom R, Stempak JM, et al
    Microbiome Heterogeneity Characterizing Intestinal Tissue and Inflammatory Bowel Disease Phenotype.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  540. HUGHES M, Qazi T, Berg A, Weinberg J, et al
    Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  541. CAO SS
    Epithelial ER Stress in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  542. CLICK B, Ramos Rivers C, Koutroubakis IE, Babichenko D, et al
    Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  543. THOMPSON KD, Connor SJ, Walls DM, Gollins J, et al
    Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  544. WU F, Huang Y, Dong F, Kwon JH, et al
    Ulcerative Colitis-Associated Long Noncoding RNA, BC012900, Regulates Intestinal Epithelial Cell Apoptosis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  545. FORBES JD, Van Domselaar G, Bernstein CN
    Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  546. SIMIAN D, Flores L, Ibanez P, Figueroa C, et al
    O-025 Disease-Related Knowledge in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S9.
    PubMed     Text format     Abstract available


  547. MORGAN P, Siegle L, Huggins J
    O-024 Improving Pneumococcal Immunization Rates Among Immunocompromised Adolescent Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S8-S9.
    PubMed     Text format     Abstract available


  548. MCBRIDE R
    O-023 YI Impact of Dedicated Inflammatory Bowel Disease (IBD) Clinic on IBD-Related Hospitalizations at Veterans Hospital.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S8.
    PubMed     Text format     Abstract available


  549. PLANTZ K, Maxwell E, Mamula P, Baldassano R, et al
    O-022 Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S8.
    PubMed     Text format     Abstract available


  550. GRANT A, Kappelman M, Martin C, Otley A, et al
    O-021 A New Domain Structure for the IMPACT-III, a Pediatric Inflammatory Bowel Disease (IBD) Health Reported Quality of Life (HRQOL) Tool.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S7-S8.
    PubMed     Text format     Abstract available


  551. VIENNOIS E, Zhao Y, Zhang M, Han M, et al
    O-016 YI Longitudinal Study of Circulating miRNA Biomarkers in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S6.
    PubMed     Text format     Abstract available


  552. JEURING SF, van den Heuvel TR, Zeegers MP, Hameeteman WH, et al
    Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  553. ANANTHAKRISHNAN AN, Cagan A, Cai T, Gainer VS, et al
    Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  554. GUERRA I, Perez-Jeldres T, Iborra M, Algaba A, et al
    Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  555. WOLF DC
    Biosimilars in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  556. BHASIN S, Singh H, Targownik LE, Israeli E, et al
    Rates and Reasons for Nonuse of Prescription Medication for Inflammatory Bowel Disease in a Referral Clinic.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  557. MIKOCKA-WALUS A, Knowles SR, Keefer L, Graff L, et al
    Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:752-62.
    PubMed     Text format     Abstract available


  558. WITTEN J, Siles R, Shen B, Yao Q, et al
    Triple Disease Combination: Familial Mediterranean Fever, Crohn's Disease, and Chronic Idiopathic Urticaria with Angioedema.
    Inflamm Bowel Dis. 2016;22:E12-3.
    PubMed     Text format    


  559. KRUGLIAK CLEVELAND N, Colman RJ, Rodriquez D, Hirsch A, et al
    Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
    Inflamm Bowel Dis. 2016;22:631-7.
    PubMed     Text format     Abstract available


  560. KJELDSEN J, Nielsen J, Larsen MD, Qvist N, et al
    Postoperative Use of Anti-TNF-alpha Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016;22:599-606.
    PubMed     Text format     Abstract available


  561. ROY A, Lichtiger S
    Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:648-53.
    PubMed     Text format     Abstract available


  562. CARRIERE J, Bretin A, Darfeuille-Michaud A, Barnich N, et al
    Exosomes Released from Cells Infected with Crohn's Disease-associated Adherent-Invasive Escherichia coli Activate Host Innate Immune Responses and Enhance Bacterial Intracellular Replication.
    Inflamm Bowel Dis. 2016;22:516-28.
    PubMed     Text format     Abstract available


  563. CLEYNEN I, Konings P, Robberecht C, Laukens D, et al
    Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:505-15.
    PubMed     Text format     Abstract available


  564. CHOI SH, Kim KW, Lee JY, Kim KJ, et al
    Diffusion-weighted Magnetic Resonance Enterography for Evaluating Bowel Inflammation in Crohn's Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2016;22:669-79.
    PubMed     Text format     Abstract available


  565. SAMAAN MA, de Jong D, Sahami S, Morgan S, et al
    Incidence and Severity of Prepouch Ileitis: A Distinct Disease Entity or a Manifestation of Refractory Pouchitis?
    Inflamm Bowel Dis. 2016;22:662-8.
    PubMed     Text format     Abstract available


    February 2016
  566. GAIDOS JK, Bickston SJ
    How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  567. SHAPIRO JM, Zoega H, Shah SA, Bright RM, et al
    Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  568. ROSA A, Abrantes P, Sousa I, Francisco V, et al
    Ulcerative Colitis Is Under Dual (Mitochondrial and Nuclear) Genetic Control.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  569. LIN JC, Lin CS, Hsu CW, Lin CL, et al
    Association Between Parkinson's Disease and Inflammatory Bowel Disease: a Nationwide Taiwanese Retrospective Cohort Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  570. THEEDE K, Holck S, Ibsen P, Kallemose T, et al
    Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  571. POULLENOT F, Seksik P, Beaugerie L, Amiot A, et al
    Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  572. PRINCE AC, Myers CE, Joyce T, Irving P, et al
    Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  573. ALEXOFF A, Roginsky G, Zhou Y, Kalenda M, et al
    Inpatient Costs for Patients with Inflammatory Bowel Disease and Acute Pancreatitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  574. GUO L, Reich J, Groshek J, Farraye FA, et al
    Social Media Use in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  575. SKOWRON KB, Lapin B, Rubin M, Hurst RD, et al
    Clostridium Difficile Infection in Ulcerative Colitis: Can Alteration of the Gut-associated Microbiome Contribute to Pouch Failure?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  576. KAO CC, Lin CL, Huang WY, Cha TL, et al
    Association Between Inflammatory Bowel Disease and Erectile Dysfunction: A Nationwide Population-Based Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  577. LIMDI JK, Aggarwal D, McLaughlin JT
    Diet and Exacerbation of Inflammatory Bowel Disease Symptoms-Food for Thought.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  578. ROSEN D, Annunziato R, Colombel JF, Dubinsky M, et al
    Transition of Inflammatory Bowel Disease Care: Assessment of Transition Readiness Factors and Disease Outcomes in a Young Adult Population.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  579. DULAI PS, Singh S, Casteele NV, Boland BS, et al
    How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  580. SEVERS M, Petersen RE, Siersema PD, Mangen MJ, et al
    Self-reported Health Care Utilization of Patients with Inflammatory Bowel Disease Correlates Perfectly with Medical Records.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  581. BHARADWAJ S, Shen B
    Therapeutic Armamentarium for Stricturing Crohn's Disease: Medical Versus Endoscopic Versus Surgical Approaches.
    Inflamm Bowel Dis. 2016;22:E7-8.
    PubMed     Text format    


  582. ALASTRUEY CL, Andujar Murcia X, Esteve Comas M
    Therapeutic Armamentarium for Stricturing Crohn's Disease: Medical Versus Endoscopic Versus Surgical Approaches.
    Inflamm Bowel Dis. 2016;22:E6.
    PubMed     Text format    


  583. MONIF GR
    Translation of Hypothesis to Therapy in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:E8-9.
    PubMed     Text format    


  584. WALTER JG, Kahn SA, Noe JD, Schurman JV, et al
    Feeling Fine: Anxiety and Depressive Symptoms in Youth with Established IBD.
    Inflamm Bowel Dis. 2016;22:402-8.
    PubMed     Text format     Abstract available


  585. MIKOCKA-WALUS A, Andrews JM, Bampton P
    Cognitive Behavioral Therapy for IBD.
    Inflamm Bowel Dis. 2016;22:E5-6.
    PubMed     Text format    


  586. SORRENTINO D
    Preclinical and Undiagnosed Crohn's Disease: The Submerged Iceberg.
    Inflamm Bowel Dis. 2016;22:476-86.
    PubMed     Text format     Abstract available


  587. HARRIS KA, Horst S, Gadani A, Nohl A, et al
    Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab.
    Inflamm Bowel Dis. 2016;22:397-401.
    PubMed     Text format     Abstract available


  588. GRAY WN, Maddux MH
    Current Transition Practices in Pediatric IBD: Findings from a National Survey of Pediatric Providers.
    Inflamm Bowel Dis. 2016;22:372-9.
    PubMed     Text format     Abstract available


  589. DUCHATELLIER CF, Kumar R, Krupoves A, Braegger C, et al
    Steroid Administration and Growth Impairment in Children with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:355-63.
    PubMed     Text format     Abstract available


  590. NAFTALI T, Reshef L, Kovacs A, Porat R, et al
    Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:293-302.
    PubMed     Text format     Abstract available


  591. OCHOA-CORTES F, Turco F, Linan-Rico A, Soghomonyan S, et al
    Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:433-49.
    PubMed     Text format     Abstract available


  592. SUNADA K, Shinozaki S, Nagayama M, Yano T, et al
    Long-term Outcomes in Patients with Small Intestinal Strictures Secondary to Crohn's Disease After Double-balloon Endoscopy-assisted Balloon Dilation.
    Inflamm Bowel Dis. 2016;22:380-6.
    PubMed     Text format     Abstract available


  593. MENYS A, Makanyanga J, Plumb A, Bhatnagar G, et al
    Aberrant Motility in Unaffected Small Bowel is Linked to Inflammatory Burden and Patient Symptoms in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:424-32.
    PubMed     Text format     Abstract available


  594. GAWRON LM, Sanders J, Steele KP, Flynn AD, et al
    Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:459-64.
    PubMed     Text format     Abstract available


  595. GOLAN D, Gross B, Miller A, Klil-Drori S, et al
    Cognitive Function of Patients with Crohn's Disease is Associated with Intestinal Disease Activity.
    Inflamm Bowel Dis. 2016;22:364-71.
    PubMed     Text format     Abstract available


    January 2016
  596. LEE HS, Park SH, Kim SH, Kim J, et al
    Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  597. ZITTAN E, Kelly OB, Kirsch R, Milgrom R, et al
    Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  598. PROSBERG MV, Vester-Andersen MK, Andersson M, Jess T, et al
    Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  599. SANTOS-ANTUNES J, Nunes AC, Lopes S, Macedo G, et al
    The Relevance of Vitamin D and Antinuclear Antibodies in Patients with Inflammatory Bowel Disease Under Anti-TNF Treatment: A Prospective Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  600. REED-KNIGHT B, Lee JL, Greenley RN, Lewis JD, et al
    Disease Activity Does Not Explain It All: How Internalizing Symptoms and Caregiver Depressive Symptoms Relate to Health-related Quality of Life Among Youth with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  601. SHAH ED, Siegel CA, Chong K, Melmed GY, et al
    Evaluating Study Withdrawal Among Biologics and Immunomodulators in Treating Ulcerative Colitis: A Meta-analysis of Controlled Clinical Trials.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  602. COTE-DAIGNEAULT J, Mehandru S, Ungaro R, Atreja A, et al
    Potential Immunomodulatory Effects of Statins in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  603. EPPINGA H, Peppelenbosch MP
    Worsening of Bowel Symptoms Through Diet in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  604. AGUAS M, Del Hoyo J, Faubel R, Nos P, et al
    Telemedicine in Inflammatory Bowel Disease: Opportunity Ahead.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  605. YARUR AJ, Jain A, Hauenstein SI, Quintero MA, et al
    Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  606. BERES NJ, Szabo D, Kocsis D, Szucs D, et al
    Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  607. CARROLL MW, Hamilton Z, Gill H, Simkin J, et al
    Pediatric Inflammatory Bowel Disease Among South Asians Living in British Columbia, Canada: A Distinct Clinical Phenotype.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  608. PIERDOMENICO M, Cesi V, Cucchiara S, Vitali R, et al
    NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  609. NISHIDA A, Hidaka K, Kanda T, Imaeda H, et al
    Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  610. BETTENWORTH D, Rieder F
    Reversibility of Stricturing Crohn's Disease-Fact or Fiction?
    Inflamm Bowel Dis. 2016;22:241-7.
    PubMed     Text format     Abstract available


  611. VAZEILLE E, Chassaing B, Buisson A, Dubois A, et al
    GipA Factor Supports Colonization of Peyer's Patches by Crohn's Disease-associated Escherichia Coli.
    Inflamm Bowel Dis. 2016;22:68-81.
    PubMed     Text format     Abstract available


  612. HERFARTH HH, Kappelman MD, Long MD, Isaacs KL, et al
    Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:224-33.
    PubMed     Text format     Abstract available


  613. MCCONNELL RA, Mahadevan U
    Use of Immunomodulators and Biologics Before, During, and After Pregnancy.
    Inflamm Bowel Dis. 2016;22:213-23.
    PubMed     Text format     Abstract available


  614. REICH KM, Fedorak RN, Madsen K, Kroeker KI, et al
    Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:92-9.
    PubMed     Text format     Abstract available


  615. MANCINA RM, Spagnuolo R, Milano M, Brogneri S, et al
    PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.
    Inflamm Bowel Dis. 2016;22:134-40.
    PubMed     Text format     Abstract available


  616. ZUO L, Li Y, Zhu W, Shen B, et al
    Mesenteric Adipocyte Dysfunction in Crohn's Disease is Associated with Hypoxia.
    Inflamm Bowel Dis. 2016;22:114-26.
    PubMed     Text format     Abstract available


    December 2015
  617. TAMBUWALA MM
    Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  618. THARIAN B, George N, Navaneethan U
    Endoscopy in the Diagnosis and Management of Complications of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  619. SPOENDLIN J, Karatas G, Furlano RI, Jick SS, et al
    Rosacea in Patients with Ulcerative Colitis and Crohn's Disease: A Population-based Case-control Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  620. RACINE A, Carbonnel F, Chan SS, Hart AR, et al
    Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  621. HOURIGAN SK, Sears CL, Oliva-Hemker M
    Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  622. WINTER R, Norgard BM, Friedman S
    Treatment of the Pregnant Patient with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  623. KAPLAN M, Yuksel M, Ates I, Yaln Kilic ZM, et al
    Are sTWEAK and IL-17A Levels in Inflammatory Bowel Disease Associated with Disease Activity and Etiopathogenesis?
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  624. SUNSERI WM, Kugathasan S, Keljo DJ, Greer JB, et al
    IBD LIVE Case Series-Case 3: Very Early-Onset Inflammatory Bowel Disease: When Genetic Testing Proves Beneficial.
    Inflamm Bowel Dis. 2015;21:2958-2968.
    PubMed     Text format    


  625. ISAACS KL, Arora S
    Navigating the Affordable Care Act and the Patient with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015;21:2969-74.
    PubMed     Text format     Abstract available


  626. PRIYAMVADA S, Gomes R, Gill RK, Saksena S, et al
    Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease-Associated Diarrhea.
    Inflamm Bowel Dis. 2015;21:2926-35.
    PubMed     Text format     Abstract available


  627. HIEJIMA E, Nakase H, Heike T
    Reply: To PMID 25946569.
    Inflamm Bowel Dis. 2015;21:E30-1.
    PubMed     Text format    


    November 2015
  628. LASCURAIN L, Jensen MK, Guthery SL, Holmen J, et al
    Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  629. LONG MD, Weaver K, Kappelman MD, Herfarth HH, et al
    Photosensitivity to Ultraviolet Light in Patients with Inflammatory Bowel Disease Newly Initiating Immunosuppressive Therapy.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  630. AHN HS
    Reply to: Food Additives Should Not be Ruled Out as the Possible Causative Factors of Inflammatory Bowel Disease in Korea.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  631. TORMEY LK, Farraye FA, PaascheOrlow MK
    Understanding Health Literacy and its Impact on Delivering Care to Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  632. AHMED S, Melmed G, McGovern D, Robbins LA, et al
    Nonbloody Diarrhea but Not Significant Weight Loss at Diagnosis Is Associated with the Development of Denovo Crohn's Disease After Ileal Pouch-anal Anastomosis for Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  633. DEBRUYN J, Fonseca K, Ghosh S, Panaccione R, et al
    Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  634. LOPEZ-SILES M, Martinez-Medina M, Suris-Valls R, Aldeguer X, et al
    Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  635. SANDS BE, Joshi S, Haddad J, Freudenberg JM, et al
    Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  636. QIN X
    Food Additives Should Not Be Ruled Out as the Possible Causative Factors of Inflammatory Bowel Disease in Korea.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  637. HINKS TS
    Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  638. CHANDE N, Marshall JK, Seow CH, Sandborn WJ, et al
    New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  639. SRINATH AI, Gupta N, Husain SZ
    Probing the Association of Pancreatitis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  640. VINDING KK, Elsberg H, Thorkilgaard T, Belard E, et al
    Fecal Calprotectin Measured By Patients at Home Using Smartphones-A New Clinical Tool in Monitoring Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  641. GISBERT JP, Barreiro-de Acosta M, Esteve M, Garcia-Sanchez V, et al
    Physician Perspectives on Unresolved Issues in the Management of Ulcerative Colitis: The UC Horizons Project.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  642. NEILSON K, Ftanou M, Monshat K, Salzberg M, et al
    A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  643. ZELMAN-TOISTER E, Bakos E, Cohen S, Zigmond E, et al
    CD151 Regulates T-Cell Migration in Health and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  644. SARTINI A, Di Girolamo M, Bertani A, Villa E, et al
    "Blindly" ADA Dose Escalation to 80 mg Weekly in Crohn's Disease Patients with LOR: Is It Cost Effective or Not?
    Inflamm Bowel Dis. 2015;21:E27-8.
    PubMed     Text format    


    October 2015
  645. UHLIG HH, Schwerd T
    From Genes to Mechanisms: The Expanding Spectrum of Monogenic Disorders Associated with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  646. FIGUEIREDO VC, Markworth JF, Durainayagam BR, Pileggi CA, et al
    Impaired Ribosome Biogenesis and Skeletal Muscle Growth in a Murine Model of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  647. PUTIGNANI L, Del Chierico F, Vernocchi P, Cicala M, et al
    Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  648. BITTON A, Vutcovici M, Sewitch M, Suissa S, et al
    Mortality Trends in Crohn's Disease and Ulcerative Colitis: A Population-based Study in Quebec, Canada.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  649. SASAKI MM, Skol AD, Hungate EA, Bao R, et al
    Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  650. DESILETS M, Deng X, Rao C, Ensminger AW, et al
    Genome-based Definition of an Inflammatory Bowel Disease-associated Adherent-Invasive Escherichia coli Pathovar.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


    September 2015
  651. GERBARG PL, Jacob VE, Stevens L, Bosworth BP, et al
    The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  652. SHAH SL, Siegel CA
    Increasing Patient Activation Could Improve Outcomes for Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  653. HOLUBAR SD, Holder-Murray J, Flasar M, Lazarev M, et al
    Anti-Tumor Necrosis Factor-alpha Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position Paper.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  654. JANSE IC, Koldijk MJ, Spekhorst LM, Vila AV, et al
    Identification of Clinical and Genetic Parameters Associated with Hidradenitis Suppurativa in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  655. YE BD, Choi H, Hong M, Yun WJ, et al
    Identification of Ten Additional Susceptibility Loci for Ulcerative Colitis Through Immunochip Analysis in Koreans.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  656. MAKKAR R, Graff LA, Bharadwaj S, Lopez R, et al
    Psychological Factors in Irritable Pouch Syndrome and Other Pouch Disorders.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  657. LIMDI JK, Aggarwal D, McLaughlin JT
    Dietary Practices and Beliefs in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  658. MCCOMBIE A, Gearry R, Andrews J, Mulder R, et al
    Does Computerized Cognitive Behavioral Therapy Help People with Inflammatory Bowel Disease? A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  659. HERMAN ML, Kane SV
    Treatment Nonadherence in Inflammatory Bowel Disease: Identification, Scope, and Management Strategies.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  660. ROSEN DJ, Dubinsky MC
    The Evolving Role of Thiopurines for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  661. KOUTROUBAKIS IE, Regueiro M, Schoen RE, Ramos-Rivers C, et al
    Multiyear Patterns of Serum Inflammatory Biomarkers and Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  662. PENNINCK E, Fumery M, Armengol-Debeir L, Sarter H, et al
    Postoperative Complications in Pediatric Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  663. HOVDE O, Smastuen MC, Hoivik ML, Bernklev T, et al
    Mortality and Causes of Death in Ulcerative Colitis: Results from 20 Years of Follow-up in the IBSEN Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  664. JOOSSE ME, Samsom JN, van der Woude CJ, Escher JC, et al
    The Role of Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Alpha Agents in Children and Adolescents with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015;21:2214-21.
    PubMed     Text format     Abstract available


  665. GREGORI D
    Reply to Are Worries and Concerns Information Side Effects?
    Inflamm Bowel Dis. 2015;21:E23.
    PubMed     Text format    


  666. BERROA E, Fernandez-Salazar L, Rodriguez McCullough N, Garrote Adrados JA, et al
    Are Worries and Concerns Information Side Effects?
    Inflamm Bowel Dis. 2015;21:E22.
    PubMed     Text format    


    August 2015
  667. GIBSON DJ, Elliott L, McDermott E, Tosetto M, et al
    Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  668. ANANTHAKRISHNAN AN, Cagan A, Cai T, Gainer VS, et al
    Identification of Nonresponse to Treatment Using Narrative Data in an Electronic Health Record Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  669. LEE AJ, Kraemer DF, Smotherman C, Eid E, et al
    Providing Our Fellows in Training with Education on Inflammatory Bowel Disease Health Maintenance to Improve the Quality of Care in Our Health Care System.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  670. LEE KK, Jharap B, Maser EA, Colombel JF, et al
    Impact of Concomitant Endometriosis on Phenotype and Natural History of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  671. CRISTOBAL I, Manso R, Gonzalez-Alonso P, Madoz-Gurpide J, et al
    Clinical Value of miR-26b Discriminating Ulcerative Colitis-associated Colorectal Cancer in the Subgroup of Patients with Metastatic Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  672. O'CONNOR A, Packey CD, Akbari M, Moss AC, et al
    Mesalamine, but Not Sulfasalazine, Reduces the Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: An Agent-specific Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  673. HASHASH JG, Chintamaneni P, Ramos Rivers CM, Koutroubakis IE, et al
    Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4-year Prospective Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  674. TRIER MOLLER F, Andersen V, Andersson M, Jess T, et al
    Hospital Admissions, Biological Therapy, and Surgery in Familial and Sporadic Cases of Inflammatory Bowel Disease: A Population-Based Cohort Study 1977-2011.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  675. VALENTINO PL, Feldman BM, Walters TD, Griffiths AM, et al
    Abnormal Liver Biochemistry Is Common in Pediatric Inflammatory Bowel Disease: Prevalence and Associations.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  676. MCCURDY JD, Enders FT, Jones A, Killian JM, et al
    Detection of Cytomegalovirus in Patients with Inflammatory Bowel Disease: Where to Biopsy and How Many Biopsies?
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  677. SLEVIN SM, Egan LJ
    New Insights into the Mechanisms of Action of Anti-Tumor Necrosis Factor-alpha Monoclonal Antibodies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  678. DEL PINTO R, Pietropaoli D, Chandar AK, Ferri C, et al
    Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  679. STALLHOFER J, Friedrich M, Konrad-Zerna A, Wetzke M, et al
    Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-alpha and Modulated by IL23R Genotype Status.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  680. BOLLEN L, Vande Casteele N, Peeters M, Van Assche G, et al
    The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  681. POLYTARCHOU C, Oikonomopoulos A, Mahurkar S, Touroutoglou A, et al
    Assessment of Circulating MicroRNAs for the Diagnosis and Disease Activity Evaluation in Patients with Ulcerative Colitis by Using the Nanostring Technology.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  682. BOYLE M, Ting A, Cury DB, Nanda K, et al
    Adherence to Rectal Mesalamine in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  683. VANHOVE W, Peeters PM, Staelens D, Schraenen A, et al
    Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  684. LEAL MC, Dabritz J
    Immunoregulatory Role of Myeloid-derived Cells in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  685. YAMAMOTO-FURUSHO JK, Fonseca-Camarillo G
    Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  686. DITISHEIM S, Fournier N, Juillerat P, Pittet V, et al
    Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  687. ALLEGRETTI JR, Borges L, Lucci M, Chang M, et al
    Risk Factors for Rehospitalization Within 90 Days in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  688. MONAGHAN TM, Cockayne A, Mahida YR
    Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015;21:1957-1966.
    PubMed     Text format     Abstract available


  689. SHEN J, Mao AP, Zhu MM, Zhao P, et al
    Ulcerative Colitis Database: An Integrated Database and Toolkit for Gene Function and Medication Involved in Ulcerative Colitis.
    Inflamm Bowel Dis. 2015;21:1872-1882.
    PubMed     Text format     Abstract available


  690. HUTH K, Benchimol EI, Aglipay M, Mack DR, et al
    Strategies to Improve Influenza Vaccination in Pediatric Inflammatory Bowel Disease Through Education and Access.
    Inflamm Bowel Dis. 2015;21:1761-1768.
    PubMed     Text format     Abstract available


  691. BOUSVAROS A
    Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug.
    Inflamm Bowel Dis. 2015;21:1750-1751.
    PubMed     Text format    


  692. GASHIN L, Cheifetz AS
    Reply to Use of CT Scan in Ulcerative Colitis Patients Presenting to the Emergency Department.
    Inflamm Bowel Dis. 2015;21:E21.
    PubMed     Text format    


  693. SEMINERIO JL, Koutroubakis IE, Ramos-Rivers C, Hashash JG, et al
    Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  694. STIDHAM RW, Waljee AK, Day NM, Bergmans CL, et al
    Reply to Body Fat Composition Predicts Infectious Complications After Bowel Resection in Crohn's Disease.
    Inflamm Bowel Dis. 2015;21:E19-20.
    PubMed     Text format    


  695. LI Y, Zhu W
    Body Fat Composition Predicts Infectious Complications After Bowel Resection in Crohn's Disease.
    Inflamm Bowel Dis. 2015;21:E19.
    PubMed     Text format    


    July 2015
  696. ANANTHAKRISHNAN AN, Khalili H, Song M, Higuchi LM, et al
    High School Diet and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  697. DAVE M, Mehta K, Luther J, Baruah A, et al
    Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  698. FULLER-THOMSON E, West KJ, Sulman J, Baird SL, et al
    Childhood Maltreatment Is Associated with Ulcerative Colitis but Not Crohn's Disease: Findings from a Population-based Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  699. RISPO A, Testa A, De Palma GD, Donetto S, et al
    Different Profile of Efficacy of Thiopurines in Ulcerative Colitis and Crohn's Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  700. GREENLEY RN, Gumidyala AP, Nguyen E, Plevinsky JM, et al
    Can You Teach a Teen New Tricks? Problem Solving Skills Training Improves Oral Medication Adherence in Pediatric Patients with Inflammatory Bowel Disease Participating in a Randomized Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  701. DOSHI-VELEZ F, Avillach P, Palmer N, Bousvaros A, et al
    Prevalence of Inflammatory Bowel Disease Among Patients with Autism Spectrum Disorders.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  702. FULLER-THOMSON E, Lateef R, Sulman J
    Robust Association Between Inflammatory Bowel Disease and Generalized Anxiety Disorder: Findings from a Nationally Representative Canadian Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  703. SHUKLA T, Singh S, Loftus EV Jr, Bruining DH, et al
    Antiviral Therapy in Steroid-refractory Ulcerative Colitis with Cytomegalovirus: Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  704. GOREN I, Yahav L, Tulchinsky H, Dotan I, et al
    Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  705. KINNUCAN J, Tomal J, Rubin DT
    U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  706. CHEN P, Bakke D, Kolodziej L, Lodolce J, et al
    Antrum Mucosal Protein-18 Peptide Targets Tight Junctions to Protect and Heal Barrier Structure and Function in Models of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  707. KINI AT, Thangaraj KR, Simon E, Shivappagowdar A, et al
    Aberrant Niche Signaling in the Etiopathogenesis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  708. HENAO MP, Bewtra M, Osterman MT, Aberra FN, et al
    Measurement of Inflammatory Bowel Disease Symptoms: Reliability of an Abbreviated Approach to Data Collection.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  709. PEREIRA C, Gracio D, Teixeira JP, Magro F, et al
    Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  710. WATERMAN M, Knight J, Dinani A, Xu W, et al
    Predictors of Outcome in Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  711. JABEEN R, Miller L, Yao W, Gupta S, et al
    Altered STAT4 Isoform Expression in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  712. MANES G, Fontana P, de Nucci G, Radaelli F, et al
    Colon Cleansing for Colonoscopy in Patients with Ulcerative Colitis: Efficacy and Acceptability of a 2-L PEG Plus Bisacodyl Versus 4-L PEG.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  713. VESTER-ANDERSEN MK, Prosberg MV, Vind I, Andersson M, et al
    Low Risk of Unemployment, Sick Leave, and Work Disability Among Patients with Inflammatory Bowel Disease: A 7-year Follow-up Study of a Danish Inception Cohort.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  714. CHIA R, Borum ML
    African Americans May Access the Emergency Department for Inflammatory Bowel Disease Care More Often than Whites.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  715. NABI S
    Use of CT Scan in Ulcerative Colitis Patients Presenting to the Emergency Department.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  716. VAVRICKA SR, Schoepfer A, Scharl M, Lakatos PL, et al
    Extraintestinal Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  717. MORENO-RINCON E, Benitez JM, Serrano-Ruiz FJ, Vazquez-Moron JM, et al
    Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal.
    Inflamm Bowel Dis. 2015;21:1564-71.
    PubMed     Text format     Abstract available



  718. Elevated IL-13Ra2 in Intestinal Epithelial Cells From Ulcerative Colitis or Colorectal Cancer Initiates MAPK Pathway: RETRACTION.
    Inflamm Bowel Dis. 2015;21:1736.
    PubMed     Text format    


  719. EHRENPREIS ED, Habib I, Mazulis A, Roginsky G, et al
    Reply to Morse and Sartor.
    Inflamm Bowel Dis. 2015;21:E12.
    PubMed     Text format    


  720. ZAND A, van Deen WK, Inserra EK, Hall L, et al
    Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact.
    Inflamm Bowel Dis. 2015;21:1623-30.
    PubMed     Text format     Abstract available


  721. PARAMSOTHY S, Borody TJ, Lin E, Finlayson S, et al
    Donor Recruitment for Fecal Microbiota Transplantation.
    Inflamm Bowel Dis. 2015;21:1600-6.
    PubMed     Text format     Abstract available


  722. CERRILLO E, Beltran B, Pous S, Echarri A, et al
    Fecal Calprotectin in Ileal Crohn's Disease: Relationship with Magnetic Resonance Enterography and a Pathology Score.
    Inflamm Bowel Dis. 2015;21:1572-9.
    PubMed     Text format     Abstract available


  723. KOBOZIEV I, Jones-Hall Y, Valentine JF, Webb CR, et al
    Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases.
    Inflamm Bowel Dis. 2015;21:1652-73.
    PubMed     Text format     Abstract available


  724. WIESE DM, Beaulieu D, Slaughter JC, Horst S, et al
    Use of Endoscopic Ultrasound to Guide Adalimumab Treatment in Perianal Crohn's Disease Results in Faster Fistula Healing.
    Inflamm Bowel Dis. 2015;21:1594-9.
    PubMed     Text format     Abstract available


  725. GRAY WN, Resmini AR, Baker KD, Holbrook E, et al
    Concerns, Barriers, and Recommendations to Improve Transition from Pediatric to Adult IBD Care: Perspectives of Patients, Parents, and Health Professionals.
    Inflamm Bowel Dis. 2015;21:1641-51.
    PubMed     Text format     Abstract available


  726. SARO C, Ceballos D, Munoz F, De la Coba C, et al
    Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients.
    Inflamm Bowel Dis. 2015;21:1631-40.
    PubMed     Text format     Abstract available


  727. HIEJIMA E, Kawai T, Nakase H, Tsuruyama T, et al
    Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015;21:1529-40.
    PubMed     Text format     Abstract available


  728. PILLET S, Jarlot C, Courault M, Del Tedesco E, et al
    Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2015;21:1580-6.
    PubMed     Text format     Abstract available


  729. YARUR AJ, Rubin DT
    Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2015;21:1709-18.
    PubMed     Text format     Abstract available


  730. CHANDAR AK, Singh S, Murad MH, Peyrin-Biroulet L, et al
    Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn's Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015;21:1695-708.
    PubMed     Text format     Abstract available


  731. FLANAGAN PK, Chiewchengchol D, Wright HL, Edwards SW, et al
    Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D.
    Inflamm Bowel Dis. 2015;21:1499-510.
    PubMed     Text format     Abstract available


    June 2015
  732. PEDERSEN N, Munkholm P
    Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  733. KHALILI H, Chan AT
    Reply to Comments on Measures of Obesity and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  734. AHN HS
    Increased Incidence of Inflammatory Bowel Disease in Korea May Not Be Explained by Food Additives.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  735. MENDALL M, Chan D, Kumar D
    Comments on Measures of Obesity and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  736. FONSECA-CAMARILLO G, Yamamoto-Furusho JK
    Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  737. QIN X
    How to Explain the Dramatic Increase Around 2000 but Recent Leveling Off of Inflammatory Bowel Disease in Korea?
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  738. MURTHY SK, Greenberg GR, Croitoru K, Nguyen GC, et al
    Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  739. MCCOMBIE AM, Mulder RT, Gearry RB
    Coping Strategies and Psychological Outcomes of Patients with Inflammatory Bowel Disease in the First 6 Months After Diagnosis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  740. GOTTLIEB K, Travis S, Feagan B, Hussain F, et al
    Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  741. BENDERSKA N, Dittrich AL, Knaup S, Rau TT, et al
    miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  742. CHEHOUD C, Albenberg LG, Judge C, Hoffmann C, et al
    Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  743. AGILLI M, Dogan T, Ergin G
    Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  744. HOLDER-MURRAY J, Marsicovetere P, Holubar SD
    Minimally invasive surgery for inflammatory bowel disease.
    Inflamm Bowel Dis. 2015;21:1443-58.
    PubMed     Text format     Abstract available


  745. BOYNTON K, Flynn A, Box T, Dalpiaz A, et al
    Inflammatory bowel disease education: I can hear the extension for community healthcare outcomes.
    Inflamm Bowel Dis. 2015;21:1407-8.
    PubMed     Text format    


  746. KIM SY, Park SH
    Reply to What is the Role of Diffusion-weighted Imaging in Ileocolonic Crohn's Disease?
    Inflamm Bowel Dis. 2015;21:E9-E10.
    PubMed     Text format    


  747. BUISSON A, Hordonneau C, Goutte M, Bommelaer G, et al
    What is the Role of Diffusion-weighted Imaging in Ileocolonic Crohn's Disease?
    Inflamm Bowel Dis. 2015;21:E9.
    PubMed     Text format    


  748. SUSKIND DL
    Reply to can fecal microbial transplant effectively treat Crohn's disease?
    Inflamm Bowel Dis. 2015;21:E8.
    PubMed     Text format    


  749. DAI C, Jiang M, Sun MJ
    Can fecal microbial transplant effectively treat Crohn's disease?
    Inflamm Bowel Dis. 2015;21:E8.
    PubMed     Text format    


  750. HUANG VW, Prosser C, Kroeker KI, Wang H, et al
    Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy.
    Inflamm Bowel Dis. 2015;21:1359-67.
    PubMed     Text format     Abstract available


  751. BERNSTEIN CN, Garland A, Peschken CA, Hitchon CA, et al
    Predictors of ICU Admission and Outcomes 1 Year Post-Admission in Persons with IBD: A Population-based Study.
    Inflamm Bowel Dis. 2015;21:1341-7.
    PubMed     Text format     Abstract available


  752. PANACCIONE R, Sandborn WJ, Gordon GL, Lee SD, et al
    Briakinumab for treatment of Crohn's disease: results of a randomized trial.
    Inflamm Bowel Dis. 2015;21:1329-40.
    PubMed     Text format     Abstract available


  753. BRAMHALL M, Florez-Vargas O, Stevens R, Brass A, et al
    Quality of methods reporting in animal models of colitis.
    Inflamm Bowel Dis. 2015;21:1248-59.
    PubMed     Text format     Abstract available


  754. LE PN, Greer JB, Oikonomou I, Schraut WH, et al
    IBD LIVE Case Series-Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?
    Inflamm Bowel Dis. 2015;21:1401-6.
    PubMed     Text format    


  755. WANG W, Jovel J, Halloran B, Wine E, et al
    Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria.
    Inflamm Bowel Dis. 2015;21:1419-27.
    PubMed     Text format     Abstract available


  756. LISSNER D, Schumann M, Batra A, Kredel LI, et al
    Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.
    Inflamm Bowel Dis. 2015;21:1297-305.
    PubMed     Text format     Abstract available


  757. DE VALLIERE C, Wang Y, Eloranta JJ, Vidal S, et al
    G Protein-coupled pH-sensing Receptor OGR1 Is a Regulator of Intestinal Inflammation.
    Inflamm Bowel Dis. 2015;21:1269-81.
    PubMed     Text format     Abstract available


  758. ZUBIN G, Peter L
    Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
    Inflamm Bowel Dis. 2015;21:1386-91.
    PubMed     Text format     Abstract available


  759. WRIGHT EK, Kamm MA, Teo SM, Inouye M, et al
    Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic review.
    Inflamm Bowel Dis. 2015;21:1219-28.
    PubMed     Text format     Abstract available


  760. STIDHAM RW, Waljee AK, Day NM, Bergmans CL, et al
    Body fat composition assessment using analytic morphomics predicts infectious complications after bowel resection in Crohn's disease.
    Inflamm Bowel Dis. 2015;21:1306-13.
    PubMed     Text format     Abstract available


  761. SZIGETHY E, Youk AO, Gonzalez-Heydrich J, Bujoreanu SI, et al
    Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease.
    Inflamm Bowel Dis. 2015;21:1321-8.
    PubMed     Text format     Abstract available


  762. CHANG MI, Cohen BL, Greenstein AJ
    A review of the impact of biologics on surgical complications in Crohn's disease.
    Inflamm Bowel Dis. 2015;21:1472-7.
    PubMed     Text format     Abstract available


  763. SINH P, Shen B
    Endoscopic evaluation of surgically altered bowel in patients with inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:1459-71.
    PubMed     Text format     Abstract available


    May 2015
  764. FEUERSTEIN JD, Jiang ZG, Belkin E, Lewandowski JJ, et al
    Surgery for Ulcerative Colitis Is Associated with a High Rate of Readmissions at 30 Days.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  765. COHEN RD, Dalal SR
    Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  766. VAVRICKA SR, Rogler G, Gantenbein C, Spoerri M, et al
    Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  767. LAZZERINI M, Martelossi S, Ventura A
    Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  768. BENNIKE TB, Carlsen TG, Ellingsen T, Bonderup OK, et al
    Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  769. GONDIM FA, de Oliveira GR, Teles BC, Aquino PS, et al
    Clinical and Electrodiagnostic Findings in Patients with Peripheral Neuropathy and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  770. BOOTZ F, Schmid AS, Neri D
    Alternatively Spliced EDA Domain of Fibronectin Is a Target for Pharmacodelivery Applications in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  771. MERKLEY SA, Beaulieu DB, Horst S, Duley C, et al
    Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional Treatments.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  772. CHERFANE CE, Gessel L, Cirillo D, Zimmerman MB, et al
    Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  773. VIENNOIS E, Zhao Y, Merlin D
    Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  774. LEE HS, Yang SK, Soh JS, Lee S, et al
    Short- and Long-Term Outcomes of Acute Severe Ulcerative Colitis in Korea: The 1999-2005 Cohort.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  775. KOUTSOCHRISTOU V, Zellos A, Dimakou K, Panayotou I, et al
    Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease: A Case-Control Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  776. DEZFOLI S, Horton HA, Thepyasuwan N, Berel D, et al
    Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  777. MELESSE DY, Targownik LE, Singh H, Blanchard JF, et al
    Patterns and Predictors of Long-term Nonuse of Medical Therapy Among Persons with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  778. LONG MD, Gulati A, Wohl D, Herfarth H, et al
    Immunizations in Pediatric and Adult Patients with Inflammatory Bowel Disease: A Practical Case-based Approach.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  779. ALRUBAIY L, Rikaby I, Sageer M, Hutchings HA, et al
    Systematic Review of the Clinical Disease Severity Indices for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  780. DAI C, Jiang M, Sun MJ
    Can fecal calprotection identify postoperative recurrence of Crohn's disease?
    Inflamm Bowel Dis. 2015;21:E7.
    PubMed     Text format    


  781. QIU Y
    Reply to can fecal calprotection identify postoperative recurrence of Crohn's disease?
    Inflamm Bowel Dis. 2015;21:E7.
    PubMed     Text format    


  782. WRIGHT EK, Kamm MA
    Impact of drug therapy and surgery on quality of life in Crohn's disease: a systematic review.
    Inflamm Bowel Dis. 2015;21:1187-94.
    PubMed     Text format     Abstract available


  783. LEE MN, Kang B, Choi SY, Kim MJ, et al
    Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.
    Inflamm Bowel Dis. 2015;21:1054-62.
    PubMed     Text format     Abstract available


  784. WHITEOAK SR, Felwick R, Sanchez-Elsner T, Fraser Cummings JR, et al
    MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.
    Inflamm Bowel Dis. 2015;21:1160-5.
    PubMed     Text format     Abstract available


  785. BOUGUEN G, Laharie D, Nancey S, Hebuterne X, et al
    Efficacy and safety of adalimumab 80 mg weekly in luminal Crohn's disease.
    Inflamm Bowel Dis. 2015;21:1047-53.
    PubMed     Text format     Abstract available


  786. DOTSON JL, Bashaw H, Nwomeh B, Crandall WV, et al
    Management of intra-abdominal abscesses in children with Crohn's disease: a 12-year, retrospective single-center review.
    Inflamm Bowel Dis. 2015;21:1109-14.
    PubMed     Text format     Abstract available


  787. HUANG EY, Inoue T, Leone VA, Dalal S, et al
    Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:963-72.
    PubMed     Text format     Abstract available


  788. LEWIS A, Nijhuis A, Mehta S, Kumagai T, et al
    Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets.
    Inflamm Bowel Dis. 2015;21:1141-50.
    PubMed     Text format     Abstract available


  789. PAPA A, Papa V, Marzo M, Scaldaferri F, et al
    Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing.
    Inflamm Bowel Dis. 2015;21:1204-13.
    PubMed     Text format     Abstract available


    April 2015
  790. LAZZERINI M, Martelossi S, Magazzu G, Pellegrino S, et al
    Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  791. SOH JS, Yun WJ, Kim KJ, Won CH, et al
    Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
    Inflamm Bowel Dis. 2015;21:832-9.
    PubMed     Text format     Abstract available


  792. HOLMES EA, Xiang F, Lucas RM
    Variation in incidence of pediatric Crohn's disease in relation to latitude and ambient ultraviolet radiation: a systematic review and analysis.
    Inflamm Bowel Dis. 2015;21:809-17.
    PubMed     Text format     Abstract available


  793. SCHWARTZ DA, Ghazi LJ, Regueiro M
    Guidelines for medical treatment of Crohn's perianal fistulas: critical evaluation of therapeutic trials.
    Inflamm Bowel Dis. 2015;21:737-52.
    PubMed     Text format    


  794. ONG EM, Ghazi LJ, Schwartz DA, Mortele KJ, et al
    Guidelines for imaging of Crohn's perianal fistulizing disease.
    Inflamm Bowel Dis. 2015;21:731-6.
    PubMed     Text format    


  795. SCHWARTZ DA, Ghazi LJ, Regueiro M, Fichera A, et al
    Guidelines for the multidisciplinary management of Crohn's perianal fistulas: summary statement.
    Inflamm Bowel Dis. 2015;21:723-30.
    PubMed     Text format    


  796. DOTSON JL, Kappelman MD, Chisolm DJ, Crandall WV, et al
    Racial disparities in readmission, complications, and procedures in children with Crohn's disease.
    Inflamm Bowel Dis. 2015;21:801-8.
    PubMed     Text format     Abstract available


  797. FICHERA A, Zoccali M
    Guidelines for the surgical treatment of Crohn's perianal fistulas.
    Inflamm Bowel Dis. 2015;21:753-8.
    PubMed     Text format    


  798. GRIGORAS CA, Ziakas PD, Jayamani E, Mylonakis E, et al
    ATG16L1 and IL23R variants and genetic susceptibility to crohn's disease: mode of inheritance based on meta-analysis of genetic association studies.
    Inflamm Bowel Dis. 2015;21:768-76.
    PubMed     Text format     Abstract available


  799. FALVEY JD, Hoskin T, Meijer B, Ashcroft A, et al
    Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
    Inflamm Bowel Dis. 2015;21:824-31.
    PubMed     Text format     Abstract available


  800. KEVANS D, Turpin W, Madsen K, Meddings J, et al
    Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's disease.
    Inflamm Bowel Dis. 2015;21:879-87.
    PubMed     Text format     Abstract available


  801. SHARMA S, Eckert D, Hyams JS, Mensing S, et al
    Pharmacokinetics and exposure-efficacy relationship of adalimumab in pediatric patients with moderate to severe Crohn's disease: results from a randomized, multicenter, phase-3 study.
    Inflamm Bowel Dis. 2015;21:783-92.
    PubMed     Text format     Abstract available


  802. LIU S, Zhang Y, Ren J, Li J, et al
    Microbial DNA recognition by cGAS-STING and other sensors in dendritic cells in inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:901-11.
    PubMed     Text format     Abstract available


    March 2015
  803. MATALON S, Elad H, Brazowski E, Santo E, et al
    Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis.
    Inflamm Bowel Dis. 2015;21:589-95.
    PubMed     Text format     Abstract available


  804. KURAHARA LH, Sumiyoshi M, Aoyagi K, Hiraishi K, et al
    Intestinal myofibroblast TRPC6 channel may contribute to stenotic fibrosis in Crohn's disease.
    Inflamm Bowel Dis. 2015;21:496-506.
    PubMed     Text format     Abstract available


  805. SUSKIND DL, Brittnacher MJ, Wahbeh G, Shaffer ML, et al
    Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.
    Inflamm Bowel Dis. 2015;21:556-63.
    PubMed     Text format     Abstract available


  806. BOUGUEN G, Sninsky C, Tang KL, Colombel JF, et al
    Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC.
    Inflamm Bowel Dis. 2015;21:606-14.
    PubMed     Text format     Abstract available


  807. BIANCONE L, Onali S, Petruzziello C, Calabrese E, et al
    Cancer and immunomodulators in inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:674-98.
    PubMed     Text format     Abstract available


  808. WASILEWSKI A, Storr M, Zielinska M, Fichna J, et al
    Role of G protein-coupled orphan receptors in intestinal inflammation: novel targets in inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:666-73.
    PubMed     Text format     Abstract available


  809. KANI HT, Shen B
    Male issues of the ileal pouch.
    Inflamm Bowel Dis. 2015;21:716-22.
    PubMed     Text format     Abstract available


    February 2015
  810. BOSCHETTI G, Garnero P, Moussata D, Cuerq C, et al
    Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease.
    Inflamm Bowel Dis. 2015;21:331-6.
    PubMed     Text format     Abstract available


  811. ASSA A, Vong L, Pinnell LJ, Rautava J, et al
    Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury.
    Inflamm Bowel Dis. 2015;21:297-306.
    PubMed     Text format     Abstract available


  812. KHARE V, Dammann K, Asboth M, Krnjic A, et al
    Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.
    Inflamm Bowel Dis. 2015;21:287-96.
    PubMed     Text format     Abstract available


  813. SINGH T, Levine AP, Smith PJ, Smith AM, et al
    Characterization of expression quantitative trait loci in the human colon.
    Inflamm Bowel Dis. 2015;21:251-6.
    PubMed     Text format     Abstract available


  814. CHHAYA V, Saxena S, Cecil E, Subramanian V, et al
    Impact of timing and duration of thiopurine treatment on first perianal surgery in Crohn's disease: UK population-based study (1995-2009).
    Inflamm Bowel Dis. 2015;21:385-91.
    PubMed     Text format     Abstract available


  815. QIU Y, Mao R, Chen BL, He Y, et al
    Fecal calprotectin for evaluating postoperative recurrence of Crohn's disease: a meta-analysis of prospective studies.
    Inflamm Bowel Dis. 2015;21:315-22.
    PubMed     Text format     Abstract available


  816. ZITOMERSKY NL, Atkinson BJ, Fournier K, Mitchell PD, et al
    Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD.
    Inflamm Bowel Dis. 2015;21:307-14.
    PubMed     Text format     Abstract available


  817. SIVIGNON A, de Vallee A, Barnich N, Denizot J, et al
    Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn's disease.
    Inflamm Bowel Dis. 2015;21:276-86.
    PubMed     Text format     Abstract available


  818. FRANCESCONE R, Hou V, Grivennikov SI
    Cytokines, IBD, and colitis-associated cancer.
    Inflamm Bowel Dis. 2015;21:409-18.
    PubMed     Text format     Abstract available


  819. BOLAND BS, Boyle DL, Sandborn WJ, Firestein GS, et al
    Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's disease.
    Inflamm Bowel Dis. 2015;21:323-30.
    PubMed     Text format     Abstract available


  820. ZIELINSKA M, Jarmuz A, Wasilewski A, Salaga M, et al
    Role of transient receptor potential channels in intestinal inflammation and visceral pain: novel targets in inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:419-27.
    PubMed     Text format     Abstract available


  821. BRESSENOT A, Peyrin-Biroulet L
    Histologic features predicting postoperative Crohn's disease recurrence.
    Inflamm Bowel Dis. 2015;21:468-75.
    PubMed     Text format     Abstract available


  822. ROGLER G, Vavricka S
    Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD.
    Inflamm Bowel Dis. 2015;21:400-8.
    PubMed     Text format     Abstract available


  823. KALMAN RS, Hartshorn K, Farraye FA
    Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.
    Inflamm Bowel Dis. 2015;21:428-35.
    PubMed     Text format     Abstract available


  824. AMIN J, Huang B, Yoon J, Shih DQ, et al
    Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.
    Inflamm Bowel Dis. 2015;21:445-52.
    PubMed     Text format     Abstract available


    January 2015
  825. PEYRIN-BIROULET L
    Clinical remission as defined by the Mayo Score: do we deceive ourselves?
    Inflamm Bowel Dis. 2015;21:E2-3.
    PubMed     Text format    


  826. SAMAAN MA, Feagan BG, Sandborn WJ, Levesque BG, et al
    Clinical remission as defined by the Mayo Score: do we deceive ourselves?
    Inflamm Bowel Dis. 2015;21:E3-4.
    PubMed     Text format    


  827. THAPA SD
    IBD and extent of coronary atherosclerosis.
    Inflamm Bowel Dis. 2015;21:E1.
    PubMed     Text format    


  828. OPIPARI A, Franchi L
    Role of inflammasomes in intestinal inflammation and Crohn's disease.
    Inflamm Bowel Dis. 2015;21:173-81.
    PubMed     Text format     Abstract available


  829. KOPYLOV U, Nemeth A, Koulaouzidis A, Makins R, et al
    Small bowel capsule endoscopy in the management of established Crohn's disease: clinical impact, safety, and correlation with inflammatory biomarkers.
    Inflamm Bowel Dis. 2015;21:93-100.
    PubMed     Text format     Abstract available


  830. SELVAGGI F, Pellino G, Canonico S, Sciaudone G, et al
    Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis.
    Inflamm Bowel Dis. 2015;21:79-92.
    PubMed     Text format     Abstract available


  831. LOBATON T, Hoffman I, Vermeire S, Ferrante M, et al
    Aeromonas species: an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort study.
    Inflamm Bowel Dis. 2015;21:71-8.
    PubMed     Text format     Abstract available


  832. JUILLERAT P, Sokol H, Froehlich F, Yajnik V, et al
    Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort.
    Inflamm Bowel Dis. 2015;21:60-70.
    PubMed     Text format     Abstract available


  833. LONG MD, Cadigan RJ, Cook SF, Haldeman K, et al
    Perceptions of patients with inflammatory bowel diseases on biobanking.
    Inflamm Bowel Dis. 2015;21:132-8.
    PubMed     Text format     Abstract available


  834. YANG SK, Hong M, Choi H, Zhao W, et al
    Immunochip analysis identification of 6 additional susceptibility loci for Crohn's disease in Koreans.
    Inflamm Bowel Dis. 2015;21:1-7.
    PubMed     Text format     Abstract available


  835. SERWAS NK, Kansu A, Santos-Valente E, Kuloglu Z, et al
    Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype.
    Inflamm Bowel Dis. 2015;21:40-7.
    PubMed     Text format     Abstract available


  836. SERIL DN, Yao Q, Lashner BA, Shen B, et al
    Autoimmune features are associated with chronic antibiotic-refractory pouchitis.
    Inflamm Bowel Dis. 2015;21:110-20.
    PubMed     Text format     Abstract available


  837. KIM KJ, Lee Y, Park SH, Kang BK, et al
    Diffusion-weighted MR enterography for evaluating Crohn's disease: how does it add diagnostically to conventional MR enterography?
    Inflamm Bowel Dis. 2015;21:101-9.
    PubMed     Text format     Abstract available


  838. PAPAMICHAEL K, Gils A, Rutgeerts P, Levesque BG, et al
    Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse.
    Inflamm Bowel Dis. 2015;21:182-97.
    PubMed     Text format     Abstract available


  839. STODDARD PB, Ghazi LJ, Wong-You-Cheong J, Cross RK, et al
    Magnetic resonance enterography: state of the art.
    Inflamm Bowel Dis. 2015;21:229-39.
    PubMed     Text format     Abstract available


  840. LAN A, Blachier F, Benamouzig R, Beaumont M, et al
    Mucosal healing in inflammatory bowel diseases: is there a place for nutritional supplementation?
    Inflamm Bowel Dis. 2015;21:198-207.
    PubMed     Text format     Abstract available


    December 2014
  841. WILDT S, Rumessen JJ, Nordgaard-Lassen I
    Incorrect citation and analysis in meta-analysis.
    Inflamm Bowel Dis. 2014;20:E25.
    PubMed     Text format    


    September 2014
  842. GUSEVA D, Holst K, Kaune B, Meier M, et al
    Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract.
    Inflamm Bowel Dis. 2014;20:1516-29.
    PubMed     Text format     Abstract available


  843. ASCOLANI M, Mescoli C, Palmieri G, Sica G, et al
    Colonic phenotype of the ileum in Crohn's disease: a prospective study before and after ileocolonic resection.
    Inflamm Bowel Dis. 2014;20:1555-61.
    PubMed     Text format     Abstract available


  844. MANSER CN, Frei P, Grandinetti T, Biedermann L, et al
    Risk factors for repetitive ileocolic resection in patients with Crohn's disease: results of an observational cohort study.
    Inflamm Bowel Dis. 2014;20:1548-54.
    PubMed     Text format     Abstract available


  845. SVRCEK M, Piton G, Cosnes J, Beaugerie L, et al
    Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study.
    Inflamm Bowel Dis. 2014;20:1584-92.
    PubMed     Text format     Abstract available


  846. CARUSO A, D'Inca R, Scarpa M, Manfrin P, et al
    Diffusion-weighted magnetic resonance for assessing ileal Crohn's disease activity.
    Inflamm Bowel Dis. 2014;20:1575-83.
    PubMed     Text format     Abstract available


  847. PLEVINSKY JM, Greenley RN
    Exploring health-related quality of life and social functioning in adolescents with inflammatory bowel diseases after attending camp oasis and participating in a Facebook group.
    Inflamm Bowel Dis. 2014;20:1611-7.
    PubMed     Text format     Abstract available


  848. SHERMAN J, Greenstein AJ, Greenstein AJ
    Ileal j pouch complications and surgical solutions: a review.
    Inflamm Bowel Dis. 2014;20:1678-85.
    PubMed     Text format     Abstract available


  849. LI Y, Zhu W, Gong J, Zuo L, et al
    Influence of exclusive enteral nutrition therapy on visceral fat in patients with Crohn's disease.
    Inflamm Bowel Dis. 2014;20:1568-74.
    PubMed     Text format     Abstract available


  850. WRIGHT EK, De Cruz P, Gearry R, Day AS, et al
    Fecal biomarkers in the diagnosis and monitoring of Crohn's disease.
    Inflamm Bowel Dis. 2014;20:1668-77.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: